MYOV


Line plots across dimensions of each concept
Line plots across concepts
Tables

Table of contents



us-gaap:CommonStockValue

us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

us-gaap:WeightedAverageNumberOfSharesOutstandingBasic

us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted

us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecurities

us-gaap:EarningsPerShareBasic

us-gaap:EarningsPerShareDiluted

us-gaap:EarningsPerShareBasicAndDiluted

us-gaap:AllocatedShareBasedCompensationExpense
us-gaap:IncomeStatementLocation
us-gaap:StatementScenario, us-gaap:TitleOfIndividual

us-gaap:ComprehensiveIncomeNetOfTax
us-gaap:ProductOrService
us-gaap:CostOfGoodsAndServicesSold

us-gaap:GeneralAndAdministrativeExpense
us-gaap:CounterpartyName, us-gaap:RelatedPartyTransactionsByRelatedParty

us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest

us-gaap:IncomeTaxExpenseBenefit

us-gaap:InterestExpense
us-gaap:CounterpartyName, us-gaap:DebtInstrument, us-gaap:LongtermDebtType
us-gaap:CounterpartyName, us-gaap:DebtInstrument, us-gaap:LongtermDebtType, us-gaap:RelatedPartyTransactionsByRelatedParty

us-gaap:NetIncomeLoss
us-gaap:StatementEquityComponents

us-gaap:OperatingExpenses

us-gaap:OperatingIncomeLoss

us-gaap:OtherComprehensiveIncomeLossNetOfTax
us-gaap:StatementEquityComponents

us-gaap:OtherNonoperatingIncomeExpense

us-gaap:ResearchAndDevelopmentExpense

us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:CounterpartyName, us-gaap:ProductOrService
us-gaap:ProductOrService

us-gaap:Revenues

us-gaap:SellingGeneralAndAdministrativeExpense
us-gaap:CounterpartyName, us-gaap:RelatedPartyTransactionsByRelatedParty
us-gaap:RelatedPartyTransactionsByRelatedParty

us-gaap:Assets

us-gaap:Liabilities

us-gaap:LiabilitiesAndStockholdersEquity

us-gaap:StockholdersEquity
us-gaap:StatementEquityComponents

us-gaap:AssetsCurrent

us-gaap:CashAndCashEquivalentsAtCarryingValue

us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents

us-gaap:MarketableSecuritiesCurrent

us-gaap:AccountsReceivableNetCurrent

us-gaap:InventoryNet

us-gaap:PrepaidExpenseAndOtherAssetsCurrent

us-gaap:PropertyPlantAndEquipmentNet

us-gaap:OperatingLeaseRightOfUseAsset

us-gaap:OtherAssetsNoncurrent

us-gaap:AccountsPayableCurrent

us-gaap:AccruedLiabilitiesCurrent

us-gaap:LiabilitiesCurrent

us-gaap:OperatingLeaseLiabilityCurrent

us-gaap:OtherAccruedLiabilitiesCurrent
us-gaap:CounterpartyName, us-gaap:DebtInstrument, us-gaap:LongtermDebtType, us-gaap:RelatedPartyTransactionsByRelatedParty
us-gaap:LongTermDebt

us-gaap:OtherLiabilitiesNoncurrent

us-gaap:OperatingLeaseLiabilityNoncurrent

us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive

us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive

us-gaap:OperatingLeaseLiability

us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue

us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount

us-gaap:StockholdersEquity
us-gaap:StatementEquityComponents

us-gaap:CommonStockValue

us-gaap:AdditionalPaidInCapital

us-gaap:RetainedEarningsAccumulatedDeficit

us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
us-gaap:StatementEquityComponents

us-gaap:NetCashProvidedByUsedInOperatingActivities

us-gaap:NetCashProvidedByUsedInInvestingActivities

us-gaap:NetCashProvidedByUsedInFinancingActivities

us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
us-gaap:CounterpartyName
us-gaap:AmortizationOfFinancingCosts

us-gaap:IncreaseDecreaseInAccountsReceivable

us-gaap:IncreaseDecreaseInInventories

us-gaap:NetCashProvidedByUsedInOperatingActivities

us-gaap:NetIncomeLoss
us-gaap:StatementEquityComponents

us-gaap:ShareBasedCompensation

us-gaap:NetCashProvidedByUsedInInvestingActivities

us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

us-gaap:NetCashProvidedByUsedInFinancingActivities

us-gaap:EffectiveIncomeTaxRateContinuingOperations

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice

us-gaap:UnrecognizedTaxBenefits

us-gaap:DeferredTaxAssetsValuationAllowance

myov:AdjustmentsToAdditionalPaidInCapitalChangeInFairOfShareBasedCompensationExpenseRecordedToLiabilities
us-gaap:StatementEquityComponents

myov:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationLiabilitiesReclassifiedToEquity
us-gaap:StatementEquityComponents

myov:CollaborationAgreementAssetAdditions

myov:CollaborationExpense

myov:CollaborativeArrangementImputedInterest
us-gaap:CounterpartyName
myov:CollaborativeArrangementLiabilityCostsRecognizedAsFinancingCosts

myov:ContractWithCustomerLiabilityAdditions

myov:CostOfGoodsAndServicesSoldAndOperatingExpenses
us-gaap:CounterpartyName
myov:DeferredRevenueAdditions1
us-gaap:CounterpartyName, us-gaap:StatementScenario
us-gaap:ProductOrService
us-gaap:ProductOrService
myov:DeferredRevenueDeductions

myov:DepreciationandAmortizationExcludingAmortizationofDebtIssuanceCostsandDiscounts
us-gaap:FairValueByLiabilityClass
myov:FairValueRecurringBasisLiabilityGainLossIncludedInEarnings
us-gaap:FairValueByLiabilityClass
myov:FairValueRecurringBasisLiabilitySettlements

myov:IncreaseDecreaseInAccruedLiabilitiesCollaborationAgreementCurrent

myov:IncreaseDecreaseInCollaborativeArrangementLiability
us-gaap:CounterpartyName

myov:IncreaseDecreaseInDueFromCollaborators

myov:IncreaseDecreaseInInterestPayableRelatedPartyNetCurrent

myov:IncreaseDecreaseinInterestPayableRelatedPartiesCurrent

myov:IncreaseDecreaseinOperatingLeaseLiability
us-gaap:CounterpartyName
myov:LicenseAgreementRegulatoryMilestonesPaymentsReceived

myov:NoncashIncreaseDecreaseInDeferredCompensationShareBasedArrangementsLiability

myov:NoncashReclassificationOfShareBasedCompensationExpenseFromLiabilitiesToAdditionalPaidInCapital

myov:PaymentsForCollaborativeArrangement
us-gaap:CounterpartyName
us-gaap:CounterpartyName, us-gaap:IncomeStatementLocation
us-gaap:CounterpartyName, us-gaap:SubsequentEventType
myov:ProceedsFromCollaboratorsAndLicenseFeesReceived

myov:ProceedsFromMaturitiesPrepaymentsAndCallsOfMarketableSecurities
us-gaap:TitleOfIndividual, us-gaap:AwardType, us-gaap:SubsequentEventType
myov:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRightsQuarterlyPercentage
us-gaap:TitleOfIndividual, us-gaap:AwardType
myov:ShareBasedCompensationArrangementByShareBasedPaymentAwardQuarterlyAwardVestingRightsPercentage

myov:ShareBasedPaymentArrangementSettlementAndRemeasurementOfAwardsCost

myov:StockOptionsExercisedReceivable

us-gaap:AmortizationOfFinancingCostsAndDiscounts

us-gaap:ContractWithCustomerLiabilityRevenueRecognized
us-gaap:CounterpartyName
us-gaap:CounterpartyName, us-gaap:SubsequentEventType
us-gaap:CounterpartyName, us-gaap:IncomeStatementLocation, us-gaap:RelatedPartyTransaction, us-gaap:RelatedPartyTransactionsByRelatedParty
us-gaap:CostsAndExpensesRelatedParty
us-gaap:CounterpartyName, us-gaap:Range, us-gaap:IncomeStatementLocation, us-gaap:RelatedPartyTransaction, us-gaap:RelatedPartyTransactionsByRelatedParty
us-gaap:CounterpartyName, us-gaap:RelatedPartyTransaction
us-gaap:CounterpartyName, us-gaap:RelatedPartyTransaction, us-gaap:RelatedPartyTransactionsByRelatedParty

us-gaap:ForeignCurrencyTransactionGainBeforeTax

us-gaap:ForeignCurrencyTransactionGainLossBeforeTax

us-gaap:IncreaseDecreaseInAccountsPayableTrade

us-gaap:IncreaseDecreaseInAccruedLiabilities

us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities

us-gaap:IncreaseDecreaseInContractWithCustomerLiability

us-gaap:IncreaseDecreaseInDeferredRevenue

us-gaap:IncreaseDecreaseInDueToRelatedPartiesCurrent

us-gaap:IncreaseDecreaseInOperatingLeaseLiability

us-gaap:IncreaseDecreaseInOtherCurrentAssets

us-gaap:IncreaseDecreaseInOtherOperatingAssets

us-gaap:IncreaseDecreaseInOtherOperatingLiabilities

us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets

us-gaap:InterestExpenseRelatedParty
us-gaap:CounterpartyName, us-gaap:DebtInstrument, us-gaap:LongtermDebtType, us-gaap:RelatedPartyTransactionsByRelatedParty

us-gaap:InvestmentIncomeInterest

us-gaap:LeaseCost

us-gaap:OperatingLeaseCost

us-gaap:OperatingLeasePayments

us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent

us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent

us-gaap:OtherNoncashIncomeExpense

us-gaap:PaymentsToAcquireMarketableSecurities
us-gaap:CounterpartyName
us-gaap:ProceedsFromCollaborators

us-gaap:ProceedsFromRelatedPartyDebt
us-gaap:CounterpartyName, us-gaap:DebtInstrument, us-gaap:LongtermDebtType, us-gaap:RelatedPartyTransaction, us-gaap:SubsequentEventType

us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities

us-gaap:ProceedsFromStockOptionsExercised

us-gaap:RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer
us-gaap:CounterpartyName
us-gaap:ProductOrService
us-gaap:StatementScenario, us-gaap:TitleOfIndividual
us-gaap:SeveranceCosts1

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost
us-gaap:StatementScenario, us-gaap:TitleOfIndividual
us-gaap:TitleOfIndividual
us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
us-gaap:TitleOfIndividual, us-gaap:AwardType
us-gaap:TitleOfIndividual, us-gaap:AwardType, us-gaap:SubsequentEventType

us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
us-gaap:StatementEquityComponents

us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
us-gaap:StatementEquityComponents

us-gaap:VariableLeaseCost

dei:EntityPublicFloat

myov:AccruedAndOtherLiabilitiesCurrent

myov:AccruedCommercialExpensesCurrent

myov:AccruedLiabilitiesCollaborationAgreementCurrent
us-gaap:CounterpartyName
us-gaap:CounterpartyName
myov:AccruedLiabilitiesCollaborationAgreementReimbursementOfExpensesCurrent
us-gaap:CounterpartyName, us-gaap:IncomeStatementLocation
us-gaap:CounterpartyName
myov:AccruedLiabilitiesCollaborationAgreementShareOfProfitsCurrent

myov:AccruedResearchandDevelopmentCurrent

myov:AccruedSalesDiscountsRebatesAndAllowancesCurrent

myov:CollaborationAgreementAsset

myov:CollaborativeArrangementLiability
us-gaap:CounterpartyName
us-gaap:CounterpartyName, us-gaap:FairValueByMeasurementFrequency

myov:CollaborativeArrangementLiabilityCurrent

myov:CollaborativeArrangementLiabilityNoncurrent
us-gaap:AwardType, us-gaap:MeasurementInputType
myov:DeferredCompensationShareBasedArrangementsLiabilitiesCurrentAndNoncurrentMeasurementInput

myov:DeferredNetProductRevenueCurrent

myov:DeferredTaxAssetsLeasingArrangements

myov:DueFromCollaborators
us-gaap:FairValueByLiabilityClass
myov:FairValueRecurringBasisLiabilityValue

myov:LesseeOperatingLeaseLiabilityToBePaidDueAfterYearFour
us-gaap:RealEstateAndAccumulatedDepreciationDescriptionOfProperty, us-gaap:PropertyPlantAndEquipmentByType
myov:LesseeOperatingLeaseRestrictionorCovenantReducedLetterofCreditifConditionsareMet
us-gaap:RealEstateAndAccumulatedDepreciationDescriptionOfProperty, us-gaap:PropertyPlantAndEquipmentByType
myov:LesseeOperatingSubleaseAreaofLeased
us-gaap:CounterpartyName, us-gaap:RelatedPartyTransactionsByRelatedParty
myov:RelatedPartyOwnershipInterestHeldByRelatedParty

myov:SocialSecurityTaxEmployerDeferralCARESAct

us-gaap:AccruedProfessionalFeesCurrent
us-gaap:OtherCommitments
us-gaap:AccruedRoyaltiesCurrentAndNoncurrent

us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
us-gaap:RealEstateAndAccumulatedDepreciationDescriptionOfProperty, us-gaap:PropertyPlantAndEquipmentByType
us-gaap:AreaOfRealEstateProperty

us-gaap:AssetsFairValueDisclosure
us-gaap:FairValueByAssetClass
us-gaap:FairValueByAssetClass, us-gaap:FairValueByFairValueHierarchyLevel
us-gaap:FairValueByAssetClass, us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementFrequency
us-gaap:FairValueByAssetClass, us-gaap:FairValueByMeasurementFrequency
us-gaap:FairValueByFairValueHierarchyLevel
us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementFrequency
us-gaap:FairValueByMeasurementFrequency
us-gaap:FairValueByAssetClass
us-gaap:CashAndCashEquivalentsFairValueDisclosure
us-gaap:FairValueByAssetClass, us-gaap:FairValueByMeasurementFrequency

us-gaap:CashCashEquivalentsAndShortTermInvestments
us-gaap:PlanName
us-gaap:CommonStockCapitalSharesReservedForFutureIssuance

us-gaap:ContractWithCustomerLiability

us-gaap:DeferredCompensationShareBasedArrangementsLiabilityCurrent
us-gaap:AwardType, us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementFrequency
us-gaap:DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent
us-gaap:AwardType, us-gaap:FairValueByMeasurementFrequency

us-gaap:DeferredRevenue
us-gaap:ProductOrService

us-gaap:DeferredRevenueCurrent
us-gaap:ProductOrService

us-gaap:DeferredRevenueNoncurrent
us-gaap:ProductOrService

us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets

us-gaap:DeferredTaxAssetsGross

us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign

us-gaap:DeferredTaxAssetsOther

us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch

us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost

us-gaap:DeferredTaxLiabilitiesLeasingArrangements

us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment

us-gaap:DueToRelatedPartiesCurrent
us-gaap:CounterpartyName, us-gaap:Range, us-gaap:RelatedPartyTransactionsByRelatedParty
us-gaap:CounterpartyName, us-gaap:RelatedPartyTransaction, us-gaap:RelatedPartyTransactionsByRelatedParty
us-gaap:CounterpartyName, us-gaap:RelatedPartyTransactionsByRelatedParty
us-gaap:RelatedPartyTransactionsByRelatedParty
us-gaap:DueToRelatedPartiesCurrentAndNoncurrent

us-gaap:DueToRelatedPartiesNoncurrent

us-gaap:EmployeeRelatedLiabilitiesCurrent

us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized

us-gaap:InventoryFinishedGoodsNetOfReserves

us-gaap:InventoryRawMaterialsNetOfReserves

us-gaap:InventoryWorkInProcessNetOfReserves
us-gaap:FairValueByAssetClass
us-gaap:InvestmentsFairValueDisclosure
us-gaap:FairValueByAssetClass, us-gaap:FairValueByMeasurementFrequency

us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
us-gaap:PropertyPlantAndEquipmentByType
us-gaap:LettersOfCreditOutstandingAmount
us-gaap:RealEstateAndAccumulatedDepreciationDescriptionOfProperty, us-gaap:PropertyPlantAndEquipmentByType
us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementFrequency
us-gaap:LiabilitiesFairValueDisclosure
us-gaap:FairValueByMeasurementFrequency
us-gaap:CounterpartyName, us-gaap:DebtInstrument, us-gaap:LongtermDebtType, us-gaap:RelatedPartyTransactionsByRelatedParty, us-gaap:SubsequentEventType
us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
us-gaap:CounterpartyName, us-gaap:DebtInstrument, us-gaap:LongtermDebtType, us-gaap:RelatedPartyTransaction, us-gaap:SubsequentEventType
us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity
us-gaap:CounterpartyName, us-gaap:DebtInstrument, us-gaap:LongtermDebtType, us-gaap:RelatedPartyTransactionsByRelatedParty
us-gaap:CounterpartyName, us-gaap:DebtInstrument, us-gaap:LongtermDebtType, us-gaap:RelatedPartyTransactionsByRelatedParty
us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
us-gaap:RealEstateAndAccumulatedDepreciationDescriptionOfProperty
us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
us-gaap:RealEstateAndAccumulatedDepreciationDescriptionOfProperty, us-gaap:PropertyPlantAndEquipmentByType
us-gaap:StatementGeographical
us-gaap:OperatingLossCarryforwards

us-gaap:RestrictedCash
dei:LegalEntity

us-gaap:RevenueRemainingPerformanceObligation
us-gaap:CounterpartyName
us-gaap:AwardType
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
us-gaap:FairValueByMeasurementFrequency
us-gaap:SharePrice

us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
us-gaap:StatementGeographical, us-gaap:TaxCreditCarryforward
us-gaap:TaxCreditCarryforwardAmount

Plots across concepts


IncomeStatement
Income Loss From Continuing Operations 
Before Income Taxes Extraordinary Items Noncontrolling Interest
Expenses
Income Tax Expense Benefit
Balance Sheet
Stockholders Equity
Assets
Property Plant And Equipment Net
Current Assets
Inventory Net
NonCurrent Assets
Property Plant And Equipment Net
Liabilities
Operating Lease Liability
Current Liabilities
Operating Lease Liability Current
Stockholders Equity
Retained Earnings Accumulated Deficit
CashFlow
Net Income Loss
NetCashProvidedByUsedInOperatingActivities
Net Income Loss
NetCashProvidedByUsedInInvestingActivities
Net Cash Provided By Used In Investing Activities
Shares
Weighted Average Number Of Share Outstanding Basic And Diluted
OperatingLeaseLiability
Operating Lease Liability Current
LesseeOperatingLeaseLiabilityPaymentsDue
Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
InventoryNet
Inventory Raw Materials Net Of Reserves

Tables

  2021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302019-06-30
us-gaap:CommonStockValue ▄▄▄▄▄▄▄0.0020.0020.0020.0020.0020.0020.002
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding █▁92.3551591.637151NANA89.74414289.30021NA
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic █▁92.3551591.637151NANA89.74414289.30021NA
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted NANANA90.09655789.74414289.3002176.468347
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount NA13.857158NANANA12.88918.043261
 us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecurities myov:RestrictedStockUnitsAndPerformanceStockUnitsNA5.170442NANANA3.603201NA
 us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecurities us-gaap:EmployeeStockOptionNA8.613006NANANA8.648078NA
 us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecurities us-gaap:WarrantNA0.07371NANANA0.073710.07331
us-gaap:EarningsPerShareBasic █▁-0.23-0.67NANA-0.75-0.37NA
us-gaap:EarningsPerShareDiluted █▁-0.23-0.67NANA-0.75-0.37NA
us-gaap:EarningsPerShareBasicAndDiluted NANA-0.8900000000000001-0.82-0.75-0.37-0.89
  2021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302019-06-30
 COGS Ratio us-gaap:ProductOrService us-gaap:Product█▁21.06311.554NANANANANA
  2021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302019-06-30
  2021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302019-06-30
us-gaap:AllocatedShareBasedCompensationExpense ▂▂█▁▁▁▁11.86311.26231.937.016.9247.8126.452
us-gaap:ComprehensiveIncomeNetOfTax █▃▁▁▂▆▂-21.591-61.66-81.363-79.594-73.481-36.335-68.723
 us-gaap:CostOfGoodsAndServicesSold us-gaap:ProductOrService myov:CollaborationAgreementNA5.261NANANANANA
 us-gaap:CostOfGoodsAndServicesSold us-gaap:ProductOrService us-gaap:Product█▁2.6221.032NANANANANA
us-gaap:GeneralAndAdministrativeExpense NANANANA31.31622.82814.152
 us-gaap:GeneralAndAdministrativeExpense us-gaap:CounterpartyName,us-gaap:RelatedPartyTransactionsByRelatedParty myov:SumitomoDainipponPharmaCo.Ltd.,us-gaap:MajorityShareholderNANANANA1.291NANA
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest █▃▁▂▃▇▃-21.74-60.749-80.411-75.003-67.196-32.188-67.591
us-gaap:IncomeTaxExpenseBenefit ▄██▁▄▇▆-0.1490.9110.952-1.154-0.1340.6720.313
us-gaap:InterestExpense ▇▇▇▃▁▁█3.4943.5053.4932.6092.1152.1843.793
us-gaap:NetIncomeLoss █▃▁▂▃▇▃-21.591-61.66-81.363-73.849-67.062-32.86-67.904
 us-gaap:NetIncomeLoss us-gaap:StatementEquityComponents us-gaap:RetainedEarnings█▁-21.591-61.66NA-73.849-67.062-32.86-67.904
us-gaap:OperatingExpenses NANANA79.69671.83767.01465.269
us-gaap:OperatingIncomeLoss █▃▁▁▂▆▂-18.346-57.322-76.949-78.317-71.837-33.681-67.591
us-gaap:OtherComprehensiveIncomeLossNetOfTax NANANA-5.745-6.419-3.475-0.819
 us-gaap:OtherComprehensiveIncomeLossNetOfTax us-gaap:StatementEquityComponents us-gaap:AccumulatedOtherComprehensiveIncomeNANANA-5.745-6.419-3.475-0.819
us-gaap:OtherNonoperatingIncomeExpense NANANA5.8916.7183.5690.705
us-gaap:ResearchAndDevelopmentExpense ▂▃▁▃▅▆█26.2830.8821.55330.45340.52144.18651.117
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax █▅▃▁▁▄▁77.90241.06325.9841.3790.033.3330.0
us-gaap:Revenues █▅▃▁▁▄▁77.90241.06324.6051.3790.033.3330.0
us-gaap:SellingGeneralAndAdministrativeExpense ▆▆█▄▂▁58.78161.21278.03649.24331.31622.828NA
  2021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302019-06-30
  2021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302019-06-30
us-gaap:Assets ▇▇▇█▁▁▂679.54727.77725.027774.214135.773126.682250.873
us-gaap:Liabilities ███▇▂▂▁1062.4671127.3961078.9921044.871335.552261.292171.306
us-gaap:LiabilitiesAndStockholdersEquity ▇▇▇█▁▁▂679.54727.77725.027774.214135.773126.682250.873
us-gaap:StockholdersEquity ▁▁▂▃▄▅█-382.927-399.626-353.965-270.657-199.779-134.6179.567
 us-gaap:StockholdersEquity us-gaap:StatementEquityComponents us-gaap:AccumulatedOtherComprehensiveIncome▁▁▁▁▃▆█-17.285-17.285-17.285-17.285-11.54-5.121-0.312
 us-gaap:StockholdersEquity us-gaap:StatementEquityComponents us-gaap:AdditionalPaidInCapital█▆▅▅▄▄▁763.755725.465709.466711.411702.695694.383649.806
 us-gaap:StockholdersEquity us-gaap:StatementEquityComponents us-gaap:CommonStock▄▄▄▄▄▄▄0.0020.0020.0020.0020.0020.0020.002
 us-gaap:StockholdersEquity us-gaap:StatementEquityComponents us-gaap:RetainedEarnings▁▁▂▃▄▅█-1129.399-1107.808-1046.148-964.785-890.936-823.874-569.929
  2021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302019-06-30
us-gaap:AssetsCurrent ▇▇▇█▁▁▂654.666702.135704.645754.027116.908109.066235.758
us-gaap:CashAndCashEquivalentsAtCarryingValue ▆▅██▁▁▃518.163484.96674.493713.52394.2184.726226.734
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents ▆▆██▁▁▃528.263494.047677.48716.5196.19786.1227.859
us-gaap:MarketableSecuritiesCurrent █▇▁▃▂▁97.84884.82610.43532.32417.08614.97NA
us-gaap:AccountsReceivableNetCurrent █▆▁14.40210.6083.57NANANANA
us-gaap:InventoryNet █▄▁6.1414.1722.611NANANANA
us-gaap:PrepaidExpenseAndOtherAssetsCurrent ██▅▂▁▃▃18.11217.56913.5368.185.6129.378.693
  2021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302019-06-30
us-gaap:PropertyPlantAndEquipmentNet █▆█▅▅▃▁3.2972.9683.32.8472.8082.4532.057
us-gaap:OperatingLeaseRightOfUseAsset ▁▂▄▅▇█▂8.8359.2529.65510.04510.42310.799.181
us-gaap:OtherAssetsNoncurrent ██▄▄▂▁▁12.74213.4157.4277.2955.6344.3733.877
  2021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302019-06-30
us-gaap:AccountsPayableCurrent ▃▃█▅▂▁▄8.6429.12217.80912.3577.0085.38810.004
us-gaap:AccruedLiabilitiesCurrent NANANA44.37740.14128.9246.258
us-gaap:LiabilitiesCurrent ▇█▇▆▁▁▁268.336307.57281.34252.07266.75752.58468.896
us-gaap:OperatingLeaseLiabilityCurrent ██▇▇▆▆▁1.9681.8861.8071.7311.6571.5850.813
us-gaap:OtherAccruedLiabilitiesCurrent ▄▃█▃▃▂▁3.5253.2315.3152.8442.9342.5362.101
  2021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302019-06-30
 us-gaap:LongTermDebt us-gaap:CounterpartyName,us-gaap:DebtInstrument,us-gaap:LongtermDebtType,us-gaap:RelatedPartyTransactionsByRelatedParty myov:SumitomoDainipponPharmaCo.Ltd.,myov:LetterAgreementwithSumitomoDainipponPharmaCo.Ltd.,us-gaap:SecuredDebt,us-gaap:MajorityShareholder███▅▁358.7358.7358.7313.7253.7NANA
us-gaap:OtherLiabilitiesNoncurrent ▁▁▄▇█▇1.2511.2482.9474.6624.9684.437NA
us-gaap:OperatingLeaseLiabilityNoncurrent ▁▃▄▅▇█▅8.1598.6859.1899.66910.12710.5719.55
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive NANA2.482NANANANA
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive NANA0.416NANANANA
  2021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302019-06-30
us-gaap:StockholdersEquity ▁▁▂▃▄▅█-382.927-399.626-353.965-270.657-199.779-134.6179.567
 us-gaap:StockholdersEquity us-gaap:StatementEquityComponents us-gaap:AccumulatedOtherComprehensiveIncome▁▁▁▁▃▆█-17.285-17.285-17.285-17.285-11.54-5.121-0.312
 us-gaap:StockholdersEquity us-gaap:StatementEquityComponents us-gaap:AdditionalPaidInCapital█▆▅▅▄▄▁763.755725.465709.466711.411702.695694.383649.806
 us-gaap:StockholdersEquity us-gaap:StatementEquityComponents us-gaap:CommonStock▄▄▄▄▄▄▄0.0020.0020.0020.0020.0020.0020.002
 us-gaap:StockholdersEquity us-gaap:StatementEquityComponents us-gaap:RetainedEarnings▁▁▂▃▄▅█-1129.399-1107.808-1046.148-964.785-890.936-823.874-569.929
us-gaap:CommonStockValue ▄▄▄▄▄▄▄0.0020.0020.0020.0020.0020.0020.002
us-gaap:AdditionalPaidInCapital █▆▅▅▄▄▁763.755725.465709.466711.411702.695694.383649.806
us-gaap:RetainedEarningsAccumulatedDeficit ▁▁▂▃▄▅█-1129.399-1107.808-1046.148-964.785-890.936-823.874-569.929
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue █▁11.86311.262NA7.016.9247.8126.41
  2021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302019-06-30
us-gaap:NetCashProvidedByUsedInOperatingActivities ▃▁▁█▂▂▁36.599-113.177-92.943574.147-48.592-61.984-66.811
us-gaap:NetCashProvidedByUsedInInvestingActivities ▅▁█▅▆▆▆-13.383-74.39121.152-15.54-2.699-12.124-0.139
us-gaap:NetCashProvidedByUsedInFinancingActivities ▁▁▃▄▄▅█11.04.13532.76161.70661.38882.19137.61
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect ▃▁▂█▃▃▃34.216-183.433-39.03620.31310.0978.08270.66
  2021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302019-06-30
 us-gaap:AmortizationOfFinancingCosts us-gaap:CounterpartyName myov:Pfizer██▁0.60.60.5NANANANA
us-gaap:IncreaseDecreaseInAccountsReceivable ▁█3.7947.038NANANANANA
us-gaap:IncreaseDecreaseInInventories █▁1.9691.561NANANANANA
us-gaap:NetCashProvidedByUsedInOperatingActivities ▃▁▁█▂▂▁36.599-113.177-92.943574.147-48.592-61.984-66.811
us-gaap:NetIncomeLoss █▃▁▂▃▇▃-21.591-61.66-81.363-73.849-67.062-32.86-67.904
 us-gaap:NetIncomeLoss us-gaap:StatementEquityComponents us-gaap:RetainedEarnings█▁-21.591-61.66NA-73.849-67.062-32.86-67.904
us-gaap:ShareBasedCompensation ▂▂█▁▁▁▁11.86311.26231.937.016.9247.8126.452
  2021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302019-06-30
us-gaap:NetCashProvidedByUsedInInvestingActivities ▅▁█▅▆▆▆-13.383-74.39121.152-15.54-2.699-12.124-0.139
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment NANA0.7370.3020.5830.1510.139
  2021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302019-06-30
us-gaap:NetCashProvidedByUsedInFinancingActivities ▁▁▃▄▄▅█11.04.13532.76161.70661.38882.19137.61
  2021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302019-06-30

Common Stock Value

us-gaap:CommonStockValue

us-gaap:CommonStockValue


Common
Period End2021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-03-31
Value2000.02000.02000.02000.02000.02000.02000.02000.02000.02000.01000.01000.01000.01000.01000.01000.01000.01000.01000.01000.01000.01000.0
Percentage of CommonStockValue100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.10.0

Weighted Average Number Of Diluted Shares Outstanding

us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding


Weighted
Period End2021-09-302021-06-302020-09-302020-06-30
Value92918989
Percentage of WeightedAverageNumberOfDilutedSharesOutstanding100.0100.0100.0100.0

Weighted Average Number Of Shares Outstanding Basic

us-gaap:WeightedAverageNumberOfSharesOutstandingBasic

us-gaap:WeightedAverageNumberOfSharesOutstandingBasic


Weighted
Period End2021-09-302021-06-302020-09-302020-06-30
Value92918989
Percentage of WeightedAverageNumberOfSharesOutstandingBasic100.0100.0100.0100.0

Weighted Average Number Of Share Outstanding Basic And Diluted

us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted

us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted


Weighted
Period End2020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302017-12-312017-09-302017-06-302016-12-312016-09-302016-06-302016-03-31
Value908989898888767067666359595954424037
Percentage of WeightedAverageNumberOfShareOutstandingBasicAndDiluted100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount

us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount

us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount


Antidilutive
Period End2021-06-302020-06-302019-06-302018-09-302018-06-302017-09-302017-06-302016-03-31
Value13128.0432616.2594115.9966584.5779273.8164040.0
Percentage of AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount100.0100.0100.0100.0100.0100.0100.00.0

us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecurities

myov:RestrictedStockUnitsAndPerformanceStockUnits


Antidilutive
Period End2021-06-302020-06-30
Value5.1704423.603201
Percentage of AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount37.328.0

us-gaap:EmployeeStockOption


Antidilutive
Period End2021-06-302020-06-302017-12-312017-09-302017-06-302016-12-312016-09-30
Value8.6130068.6480783.32.22.41.3376571.175311
Percentage of AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount62.267.10.048.162.90.00.0

us-gaap:Warrant


Antidilutive
Period End2021-06-302020-06-302019-06-302018-09-302018-06-302017-09-302017-06-302016-03-31
Value0.073710.073710.073310.073710.073710.00.00.0
Percentage of AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount0.50.60.91.21.20.00.00.0

Earnings Per Share Basic

us-gaap:EarningsPerShareBasic

us-gaap:EarningsPerShareBasic


Earnings
Period End2021-09-302021-06-302020-09-302020-06-30
Value-0.23-0.67-0.75-0.37
Percentage of EarningsPerShareBasic100.0100.0100.0100.0

Earnings Per Share Diluted

us-gaap:EarningsPerShareDiluted

us-gaap:EarningsPerShareDiluted


Earnings
Period End2021-09-302021-06-302020-09-302020-06-30
Value-0.23-0.67-0.75-0.37
Percentage of EarningsPerShareDiluted100.0100.0100.0100.0

Earnings Per Share Basic And Diluted

us-gaap:EarningsPerShareBasicAndDiluted

us-gaap:EarningsPerShareBasicAndDiluted


Earnings
Period End2021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-31
Value-0.89-0.82-0.75-0.37-0.73-0.96-0.79-0.89-1.07-1.04-0.99-0.98-0.81-0.7-0.5-0.39-0.37-0.15-0.82-0.47-0.04
Percentage of EarningsPerShareBasicAndDiluted100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

Allocated Share Based Compensation Expense

us-gaap:AllocatedShareBasedCompensationExpense

us-gaap:AllocatedShareBasedCompensationExpense


Allocated
Period End2021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302016-03-31
Value1111317.016.9247.8126.073197.9316.4524.9334.7944.7254.2443.343.2932.7492.2010.987
Percentage of AllocatedShareBasedCompensationExpense100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer47.138.20.0508.30.023.40.00.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:AllocatedShareBasedCompensationExpense us-gaap:IncomeStatementLocation

myov:CapitalizedInventory


Allocated
Period End2021-06-30
Value0.15
Percentage of AllocatedShareBasedCompensationExpense1.3
Percentage of RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer0.5
Percentage of RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer myov:CapitalizedInventory0.0

us-gaap:GeneralAndAdministrativeExpense


Allocated
Period End2020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-31
Value3.1993.7883.114144.3133.9043.0192.9542.8792.6832.2462.2522.071.3410.8920.951.3361.6460.9870.95
Percentage of AllocatedShareBasedCompensationExpense46.248.551.372.754.460.561.261.660.963.267.268.475.360.90.00.00.00.0100.00.0
Percentage of RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer0.011.40.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
Percentage of RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer us-gaap:GeneralAndAdministrativeExpense0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:ResearchAndDevelopmentExpense


Allocated
Period End2021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-31
Value5.063.9572.9893.3113.7254.0242.9595.3993.6182.5481.9141.841.8461.5611.0941.0410.6790.861.0511.060.8140.9750.01.06
Percentage of AllocatedShareBasedCompensationExpense42.735.19.447.253.851.548.727.345.639.538.838.439.136.832.831.624.739.10.00.00.00.00.00.0
Percentage of RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer20.113.40.0240.10.012.10.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
Percentage of RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer us-gaap:ResearchAndDevelopmentExpense0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:SellingGeneralAndAdministrativeExpenses


Allocated
Period End2021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-31
Value6.8037.155283.6993.1993.7883.11414
Percentage of AllocatedShareBasedCompensationExpense57.363.590.652.846.248.551.372.7
Percentage of RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer27.024.20.0268.20.011.40.00.0
Percentage of RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer us-gaap:SellingGeneralAndAdministrativeExpenses0.00.00.00.00.00.00.00.0

us-gaap:AllocatedShareBasedCompensationExpense us-gaap:StatementScenario, us-gaap:TitleOfIndividual

srt:ScenarioForecast, myov:FormerChiefExecutiveOfficer


Allocated
Period End2021-03-31
Value28
Percentage of AllocatedShareBasedCompensationExpense87.7
Percentage of RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer0.0
Percentage of RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer srt:ScenarioForecast myov:FormerChiefExecutiveOfficer0.0

Comprehensive Income Net Of Tax

us-gaap:ComprehensiveIncomeNetOfTax

us-gaap:ComprehensiveIncomeNetOfTax


Comprehensive
Period End2021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-31
Value-21591000.0-61660000.0-81363000.0-79594000.0-73481000.0-36335000.0-65736000.0-86396000.0-70287000.0-68723000.0-74734000.0-70783000.0-65842000.0-61709000.0-48138000.0-42156000.0-30024000.0-23053000.0-21534000.0-8083000.0-34712000.0-18970000.0-1657000.0
Percentage of ComprehensiveIncomeNetOfTax100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer-85.8-209.00.0-5771.90.0-109.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

Cost Of Goods And Services Sold

us-gaap:CostOfGoodsAndServicesSold us-gaap:ProductOrService

us-gaap:CostOfGoodsAndServicesSold

myov:CollaborationAgreement


Cost
Period End2021-06-30
Value5261000.0
Percentage of CostOfGoodsAndServicesSold100.0
Percentage of RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer17.8
Percentage of RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer myov:CollaborationAgreement0.0

us-gaap:Product


Cost
Period End2021-09-302021-06-30
Value2622000.01032000.0
Percentage of CostOfGoodsAndServicesSold0.019.6
Percentage of RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer10.43.5
Percentage of RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer us-gaap:Product0.00.0

General And Administrative Expense

us-gaap:GeneralAndAdministrativeExpense

us-gaap:GeneralAndAdministrativeExpense


General
Period End2020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-31
Value3122222916141210108.7427.2686.646.1414.1823.932.8982.9672.5621.657
Percentage of GeneralAndAdministrativeExpense100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer0.068.50.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:GeneralAndAdministrativeExpense us-gaap:CounterpartyName, us-gaap:RelatedPartyTransactionsByRelatedParty

myov:SumitomoDainipponPharmaCo.Ltd., us-gaap:MajorityShareholder


General
Period End2020-09-30
Value1.291
Percentage of GeneralAndAdministrativeExpense4.1
Percentage of RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer0.0
Percentage of RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer myov:SumitomoDainipponPharmaCo.Ltd. us-gaap:MajorityShareholder0.0

Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest

us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest

us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest


Income
Period End2021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302016-03-31
Value-21740000.0-60749000.0-80411000.0-75003000.0-67196000.0-32188000.0-64851000.0-85413000.0-70373000.0-67591000.0-1657000.0
Percentage of IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer-86.4-205.90.0-5438.90.0-96.60.00.00.00.00.0

Income Tax Expense Benefit

us-gaap:IncomeTaxExpenseBenefit

us-gaap:IncomeTaxExpenseBenefit


Income
Period End2021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-31
Value-149000.0911000.0952000.0-1154000.0-134000.0672000.062000.0191000.0195000.0313000.0243000.0088000.0145000.0-394000.0-213000.0-265000.01085000.0-114000.029000.08000.03000.00
Percentage of IncomeTaxExpenseBenefit100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.00.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.00.0
Percentage of RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer-0.63.10.0-83.70.02.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

Interest Expense

us-gaap:InterestExpense

us-gaap:InterestExpense


Interest
Period End2021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-03-31
Value3.4943.5053.4932.6092.1152.1841.4413.6413.7883.7933.991.6341.581.6171.1420.9040.00.00.00.00.0
Percentage of InterestExpense100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.00.00.00.00.00.0
Percentage of RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer13.911.90.0189.20.06.60.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:InterestExpense us-gaap:CounterpartyName, us-gaap:DebtInstrument, us-gaap:LongtermDebtType

myov:SumitomoDainipponPharmaCo.Ltd., myov:LetterAgreementwithSumitomoDainipponPharmaCo.Ltd., us-gaap:SecuredDebt


Interest
Period End2021-09-302021-06-302020-09-302020-06-30
Value2.8852.9042.1152.184
Percentage of InterestExpense82.682.9100.0100.0
Percentage of RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer11.59.80.06.6
Percentage of RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer myov:SumitomoDainipponPharmaCo.Ltd. myov:LetterAgreementwithSumitomoDainipponPharmaCo.Ltd. us-gaap:SecuredDebt0.00.00.00.0

us-gaap:InterestExpense us-gaap:CounterpartyName, us-gaap:DebtInstrument, us-gaap:LongtermDebtType, us-gaap:RelatedPartyTransactionsByRelatedParty

myov:SumitomoDainipponPharmaCo.Ltd., myov:LetterAgreementwithSumitomoDainipponPharmaCo.Ltd., us-gaap:SecuredDebt, us-gaap:MajorityShareholder


Interest
Period End2021-03-312020-12-312020-03-312019-12-31
Value2.8982.5691.4250.016
Percentage of InterestExpense83.098.598.90.4
Percentage of RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer0.0186.30.00.0
Percentage of RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer myov:SumitomoDainipponPharmaCo.Ltd. myov:LetterAgreementwithSumitomoDainipponPharmaCo.Ltd. us-gaap:SecuredDebt us-gaap:MajorityShareholder0.00.00.00.0

Net Income Loss

us-gaap:NetIncomeLoss

us-gaap:NetIncomeLoss


Net
Period End2021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-31
Value-21591000.0-61660000.0-81363000.0-73849000.0-67062000.0-32860000.0-64913000.0-85604000.0-70568000.0-67904000.0-75014000.0-70633000.0-65770000.0-62134000.0-48253000.0-41777000.0-29908000.0-23317000.0-21675000.0-8083000.0-34712000.0-18970000.0-1657000.0
Percentage of NetIncomeLoss100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer-85.8-209.00.0-5355.30.0-98.60.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:NetIncomeLoss us-gaap:StatementEquityComponents

us-gaap:RetainedEarnings


Net
Period End2021-09-302021-06-302020-12-312020-09-302020-06-302019-12-312019-09-302019-06-302018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-03-31
Value-21591000.0-61660000.0-73849000.0-67062000.0-32860000.0-85604000.0-70568000.0-67904000.0-70633000.0-65770000.0-62134000.0-48253000.0-41777000.0-29908000.0-23317000.0-21674000.0-8083000.0-1657000.0
Percentage of NetIncomeLoss100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer-85.8-209.0-5355.30.0-98.60.00.00.00.00.00.00.00.00.00.00.00.00.0
Percentage of RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer us-gaap:RetainedEarnings0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

Operating Expenses

us-gaap:OperatingExpenses

us-gaap:OperatingExpenses


Operating
Period End2020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-31
Value797167647867657169646047413021229.0566.72171.657
Percentage of OperatingExpenses100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer5779.30.0201.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

Operating Income Loss

us-gaap:OperatingIncomeLoss

us-gaap:OperatingIncomeLoss


Operating
Period End2021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-31
Value-18346000.0-57322000.0-76949000.0-78317000.0-71837000.0-33681000.0-51510000.0-85413000.0-70373000.0-67591000.0-74771000.0-70633000.0-65682000.0-61989000.0-48647000.0-41990000.0-30173000.0-22232000.0-21788000.0-8054000.0-34704000.0-18967000.0-1657000.0
Percentage of OperatingIncomeLoss100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer-72.9-194.30.0-5679.30.0-101.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

Other Comprehensive Income Loss Net Of Tax

us-gaap:OtherComprehensiveIncomeLossNetOfTax

us-gaap:OtherComprehensiveIncomeLossNetOfTax


Other
Period End2020-12-312020-09-302020-06-302019-12-312019-09-302019-06-302018-12-312018-09-302018-06-302017-12-312017-09-302017-06-30
Value-5745000.0-6419000.0-3475000.0-792000.0281000.0-819000.0-150000.0-72000.0425000.0-379000.0-116000.0264000.0
Percentage of OtherComprehensiveIncomeLossNetOfTax100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer-416.60.0-10.40.00.00.00.00.00.00.00.00.0

us-gaap:OtherComprehensiveIncomeLossNetOfTax us-gaap:StatementEquityComponents

us-gaap:AccumulatedOtherComprehensiveIncome


Other
Period End2020-12-312020-09-302020-06-302019-12-312019-09-302019-06-302018-12-312018-09-302018-06-302017-12-312017-09-302017-06-30
Value-5745000.0-6419000.0-3475000.0-792000.0281000.0-819000.0-150000.0-72000.0425000.0-379000.0-116000.0264000.0
Percentage of OtherComprehensiveIncomeLossNetOfTax100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer-416.60.0-10.40.00.00.00.00.00.00.00.00.0
Percentage of RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer us-gaap:AccumulatedOtherComprehensiveIncome0.00.00.00.00.00.00.00.00.00.00.00.0

Other Nonoperating Income Expense

us-gaap:OtherNonoperatingIncomeExpense

us-gaap:OtherNonoperatingIncomeExpense


Other
Period End2020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-03-31
Value5.8916.7183.5690.470.567-0.1210.705-0.1620.1210.021-0.289-0.1580.4290.138-0.342-0.1390.00.00.0
Percentage of OtherNonoperatingIncomeExpense100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.00.00.00.0
Percentage of RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer427.20.010.70.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

Research And Development Expense

us-gaap:ResearchAndDevelopmentExpense

us-gaap:ResearchAndDevelopmentExpense


Research
Period End2021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-31
Value263021304044414850515958535140342417196.1583.753140.0
Percentage of ResearchAndDevelopmentExpense100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.00.0
Percentage of RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer104.4104.60.02208.30.0132.60.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

Revenue From Contract With Customer Excluding Assessed Tax

us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax

us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax


Revenue
Period End2021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302019-06-30
Value7741251.3790.0330.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax100.0100.0100.0100.00.0100.00.0
Percentage of RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer309.5139.20.0100.00.0100.00.0

us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:CounterpartyName, us-gaap:ProductOrService

myov:Richter, myov:RYEQO


Revenue
Period End2021-09-30
Value1.7
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax2.2
Percentage of RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer6.8
Percentage of RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer myov:Richter myov:RYEQO0.0

myov:Richter, myov:RevenueRecognizedUponCompletionOfDelivery


Revenue
Period End2021-09-30
Value16
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax21.4
Percentage of RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer66.3
Percentage of RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer myov:Richter myov:RevenueRecognizedUponCompletionOfDelivery0.0

us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:ProductOrService

myov:MYFEMBREE


Revenue
Period End2021-09-302021-06-30
Value0.6291.075
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.82.6
Percentage of RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer2.53.6
Percentage of RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer myov:MYFEMBREE0.00.0

myov:ORGOVYX


Revenue
Period End2021-09-302021-06-30
Value1810
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax24.025.5
Percentage of RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer74.135.5
Percentage of RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer myov:ORGOVYX0.00.0

myov:RYEQO


Revenue
Period End2021-09-30
Value1.771
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax2.3
Percentage of RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer7.0
Percentage of RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer myov:RYEQO0.0

us-gaap:LicenseAndService


Revenue
Period End2021-09-302020-09-302020-06-30
Value310.033
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax40.60.0100.0
Percentage of RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer125.80.0100.0
Percentage of RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer us-gaap:LicenseAndService0.00.00.0

us-gaap:Product


Revenue
Period End2021-09-302021-06-30
Value2111
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax27.028.1
Percentage of RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer83.739.2
Percentage of RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer us-gaap:Product0.00.0

Revenues

us-gaap:Revenues

us-gaap:Revenues


Revenues
Period End2021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302019-06-30
Value7741241.3790.0330.0
Percentage of Revenues100.0100.0100.0100.00.0100.00.0
Percentage of RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer309.5139.20.0100.00.0100.00.0

Selling General And Administrative Expense

us-gaap:SellingGeneralAndAdministrativeExpense

us-gaap:SellingGeneralAndAdministrativeExpense


Selling
Period End2021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-31
Value5861784931222229
Percentage of SellingGeneralAndAdministrativeExpense100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer233.5207.40.03570.90.068.50.00.0

us-gaap:SellingGeneralAndAdministrativeExpense us-gaap:CounterpartyName, us-gaap:RelatedPartyTransactionsByRelatedParty

myov:SumitomoDainipponPharmaCoLtdAndSunovionPharmaceuticalsInc, us-gaap:MajorityShareholder


Selling
Period End2021-03-312020-12-31
Value2.2541.671
Percentage of SellingGeneralAndAdministrativeExpense2.93.4
Percentage of RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer0.0121.2
Percentage of RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer myov:SumitomoDainipponPharmaCoLtdAndSunovionPharmaceuticalsInc us-gaap:MajorityShareholder0.00.0

us-gaap:SellingGeneralAndAdministrativeExpense us-gaap:RelatedPartyTransactionsByRelatedParty

us-gaap:MajorityShareholder


Selling
Period End2021-09-302021-06-302020-09-302020-06-30
Value1.1731.3231.2910.114
Percentage of SellingGeneralAndAdministrativeExpense2.02.24.10.5
Percentage of RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer4.74.50.00.3
Percentage of RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer us-gaap:MajorityShareholder0.00.00.00.0

Assets

us-gaap:Assets

us-gaap:Assets


Assets
Period End2021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-03-31
Value6797277257741351261051291842501722011681541191371361631851941.9950.0
Percentage of Assets100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.00.0
Percentage of Assets100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.00.0

Liabilities

us-gaap:Liabilities

us-gaap:Liabilities


Liabilities
Period End2021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-03-31
Value1062112710781044335261214178166171168154949481551717187.993390.223
Percentage of Liabilities100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets156.4154.9148.8135.0247.1206.3202.2137.790.668.397.576.855.961.068.340.412.810.710.04.12001.00.0

Liabilities And Stockholders Equity

us-gaap:LiabilitiesAndStockholdersEquity

us-gaap:LiabilitiesAndStockholdersEquity


Liabilities
Period End2021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-03-31
Value6797277257741351261051291842501722011681541191371361631851941.9950.0
Percentage of LiabilitiesAndStockholdersEquity100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.00.0
Percentage of Assets100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.00.0

Stockholders Equity

us-gaap:StockholdersEquity

us-gaap:StockholdersEquity


Stockholders
Period End2021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-03-312016-02-02
Value-382.927-399.626-353.965-270.657-199.779-134.61-108.277-48.88817794.3344674603782118145166186-37.925-0.2230.0
Percentage of StockholdersEquity100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.00.0
Percentage of Assets-56.4-54.9-48.8-35.0-147.1-106.3-102.2-37.79.431.72.523.244.139.031.759.687.289.390.095.9-1901.00.00.0

us-gaap:StockholdersEquity us-gaap:StatementEquityComponents

us-gaap:AccumulatedOtherComprehensiveIncome


Stockholders
Period End2021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-03-312016-02-02
Value-17.285-17.285-17.285-17.285-11.54-5.121-1.646-0.823-0.031-0.3120.5070.2270.3770.4490.024-0.0910.2880.4040.140.00.0
Percentage of StockholdersEquity4.54.34.96.45.83.81.51.7-0.2-0.411.70.50.50.70.1-0.10.20.30.1-0.00.0
Percentage of Assets-2.5-2.4-2.4-2.2-8.5-4.0-1.6-0.6-0.0-0.10.30.10.20.30.0-0.10.20.20.10.00.0
Percentage of Assets us-gaap:AccumulatedOtherComprehensiveIncome0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:AdditionalPaidInCapital


Stockholders
Period End2021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-03-312016-02-02
Value763725709711702694684678657649505473430350266262256254251249171.4340.0
Percentage of StockholdersEquity-199.5-181.5-200.4-262.8-351.7-515.8-632.1-1386.93812.3816.711671.71013.2580.4582.4705.5319.4216.4174.1150.9134.1-45.9-643.00.0
Percentage of Assets112.499.797.991.9517.6548.1646.1523.6357.5259.0292.4234.8255.8227.0223.5190.3188.7155.5135.9128.6872.90.00.0
Percentage of Assets us-gaap:AdditionalPaidInCapital0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:CommonStock


Stockholders
Period End2021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-03-312016-02-02
Value0.0020.0020.0020.0020.0020.0020.0020.0020.0020.0020.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.001
Percentage of StockholdersEquity-0.0-0.0-0.0-0.0-0.0-0.0-0.0-0.00.00.00.00.00.00.00.00.00.00.00.00.0-0.0-0.40.0
Percentage of Assets0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.10.00.0
Percentage of Assets us-gaap:CommonStock0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:RetainedEarnings


Stockholders
Period End2021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-03-312016-02-02
Value-1129.399-1107.808-1046.148-964.785-890.936-823.874-791.014-726.101-640.497-569.929-502.025-427.011-356.378-290.608-228.474-180.221-138.444-108.536-85.097-63.423-55.34-1.6570.0
Percentage of StockholdersEquity294.9277.2295.6356.5446.0612.0730.51485.2-3712.2-716.3-11583.4-913.7-480.9-483.1-605.6-219.3-116.6-74.3-51.0-34.1145.9743.00.0
Percentage of Assets-166.2-152.2-144.3-124.6-656.2-650.3-746.8-560.7-348.1-227.2-290.2-211.7-211.9-188.3-191.8-130.6-101.7-66.4-45.9-32.7-2773.90.00.0
Percentage of Assets us-gaap:RetainedEarnings0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

Assets Current

us-gaap:AssetsCurrent

us-gaap:AssetsCurrent


Assets
Period End2021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-03-31
Value654702704754116109871101672351661961631501141341331591841930.1110.0
Percentage of AssetsCurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.00.0
Percentage of Assets96.396.597.297.486.186.183.085.791.194.096.497.397.297.396.497.797.797.599.499.75.60.0

Cash And Cash Equivalents At Carrying Value

us-gaap:CashAndCashEquivalentsAtCarryingValue

us-gaap:CashAndCashEquivalentsAtCarryingValue


Cash
Period End2021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312016-02-02
Value518484674713948476831302261561831541431081281291541801920.0730.00.00.0
Percentage of CashAndCashEquivalentsAtCarryingValue100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.00.00.00.0
Percentage of Assets76.366.693.092.269.466.972.464.170.990.490.290.791.893.191.293.495.094.497.699.13.70.00.00.0

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents

us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents

us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents


Cash
Period End2021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-03-312016-03-31
Value528494677716968678841312271571831541431081281800.0
Percentage of CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.00.0
Percentage of Assets77.767.993.492.570.968.073.765.271.690.890.991.091.893.191.293.497.60.0

Marketable Securities Current

us-gaap:MarketableSecuritiesCurrent

us-gaap:MarketableSecuritiesCurrent


Marketable
Period End2021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-03-31
Value9784103217142.99715270.0
Percentage of MarketableSecuritiesCurrent100.0100.0100.0100.0100.0100.0100.0100.0100.00.0
Percentage of Assets14.411.71.44.212.611.82.812.214.80.0

Accounts Receivable Net Current

us-gaap:AccountsReceivableNetCurrent

us-gaap:AccountsReceivableNetCurrent


Accounts
Period End2021-09-302021-06-302021-03-31
Value14103.57
Percentage of AccountsReceivableNetCurrent100.0100.0100.0
Percentage of Assets2.11.50.5

Inventory Net

us-gaap:InventoryNet

us-gaap:InventoryNet


Inventory
Period End2021-09-302021-06-302021-03-31
Value6141000.04172000.02611000.0
Percentage of InventoryNet100.0100.0100.0
Percentage of Assets0.90.60.4

Prepaid Expense And Other Assets Current

us-gaap:PrepaidExpenseAndOtherAssetsCurrent

us-gaap:PrepaidExpenseAndOtherAssetsCurrent


Prepaid
Period End2021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-03-31
Value1817138.185.6129.378.269129.9698.69310128.4495.7025.1395.2793.7385.1823.2211.1530.0380.0
Percentage of PrepaidExpenseAndOtherAssetsCurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.00.0
Percentage of Assets2.72.41.91.14.17.47.89.35.43.55.96.15.03.74.33.82.73.21.70.61.90.0

Property Plant And Equipment Net

us-gaap:PropertyPlantAndEquipmentNet

us-gaap:PropertyPlantAndEquipmentNet


Property
Period End2021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-03-31
Value3297000.02968000.03300000.02847000.02808000.02453000.02497000.02406000.02288000.02057000.02071000.01693000.01472000.01379000.01273000.01120000.0965000.0952000.0906000.0471000.0110000.00
Percentage of PropertyPlantAndEquipmentNet100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.00.0
Percentage of Assets0.50.40.50.42.11.92.41.91.20.81.20.80.90.91.10.80.70.60.50.25.50.0

Operating Lease Right Of Use Asset

us-gaap:OperatingLeaseRightOfUseAsset

us-gaap:OperatingLeaseRightOfUseAsset


Operating
Period End2021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-04-01
Value8.8359.2529.65510101011118.9739.1819.4
Percentage of OperatingLeaseRightOfUseAsset100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets1.31.31.31.37.78.510.58.94.93.70.0

Other Assets Noncurrent

us-gaap:OtherAssetsNoncurrent

us-gaap:OtherAssetsNoncurrent


Other
Period End2021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-03-31
Value12137.4277.2955.6344.3734.3734.6365.1623.8774.1143.8113.1612.7773.0652.0982.0983.0740.00.10.10.0
Percentage of OtherAssetsNoncurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.00.0100.0100.00.0
Percentage of Assets1.91.81.00.94.13.54.13.62.81.52.41.91.91.82.61.51.51.90.00.15.00.0

Accounts Payable Current

us-gaap:AccountsPayableCurrent

us-gaap:AccountsPayableCurrent


Accounts
Period End2021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-03-312017-03-312016-03-31
Value8.6429.12217127.0085.388156.6175.81910114.5783.3290.0
Percentage of AccountsPayableCurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.00.0
Percentage of Assets1.31.32.51.65.24.314.55.13.24.06.43.81.80.0

Accrued Liabilities Current

us-gaap:AccruedLiabilitiesCurrent

us-gaap:AccruedLiabilitiesCurrent


Accrued
Period End2020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-03-31
Value444028294544465348383830201411110.223
Percentage of AccruedLiabilitiesCurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets5.729.622.827.434.924.118.431.024.023.024.825.415.210.76.96.50.0

Liabilities Current

us-gaap:LiabilitiesCurrent

us-gaap:LiabilitiesCurrent


Liabilities
Period End2021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-03-31
Value2683072812526652855360687155474837261717186.3387.3650.223
Percentage of LiabilitiesCurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets39.542.338.832.649.241.581.141.232.627.541.627.728.531.731.119.412.610.59.93.3369.20.0

Operating Lease Liability Current

us-gaap:OperatingLeaseLiabilityCurrent

us-gaap:OperatingLeaseLiabilityCurrent


Operating
Period End2021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-04-01
Value1968000.01886000.01807000.01731000.01657000.01585000.01516000.01449000.0853000.0813000.0800000.0
Percentage of OperatingLeaseLiabilityCurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets0.30.30.20.21.21.31.41.10.50.30.0

Other Accrued Liabilities Current

us-gaap:OtherAccruedLiabilitiesCurrent

us-gaap:OtherAccruedLiabilitiesCurrent


Other
Period End2021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-03-31
Value3525000.03231000.05315000.02844000.02934000.02536000.03125000.04161000.02907000.02101000.01273000.01439000.01541000.01079000.01046000.0695000.0367000.0257000.0963000.059000.0
Percentage of OtherAccruedLiabilitiesCurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets0.50.40.70.42.22.03.03.21.60.80.70.70.90.70.90.50.30.20.50.0

Long Term Debt

us-gaap:LongTermDebt us-gaap:CounterpartyName, us-gaap:DebtInstrument, us-gaap:LongtermDebtType, us-gaap:RelatedPartyTransactionsByRelatedParty

us-gaap:LongTermDebt

myov:SumitomoDainipponPharmaCo.Ltd., myov:LetterAgreementwithSumitomoDainipponPharmaCo.Ltd., us-gaap:SecuredDebt, us-gaap:MajorityShareholder


Long
Period End2021-09-302021-06-302021-03-312020-12-312020-09-30
Value358358358313253
Percentage of LongTermDebt100.0100.0100.0100.0100.0
Percentage of Assets52.849.349.540.5186.9
Percentage of Assets myov:SumitomoDainipponPharmaCo.Ltd. myov:LetterAgreementwithSumitomoDainipponPharmaCo.Ltd. us-gaap:SecuredDebt us-gaap:MajorityShareholder0.00.00.00.00.0

Other Liabilities Noncurrent

us-gaap:OtherLiabilitiesNoncurrent

us-gaap:OtherLiabilitiesNoncurrent


Other
Period End2021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-03-31
Value1251000.01248000.02947000.04662000.04968000.04437000.03582000.00
Percentage of OtherLiabilitiesNoncurrent100.0100.0100.0100.0100.0100.0100.00.0
Percentage of Assets0.20.20.40.63.73.53.40.0

Operating Lease Liability Noncurrent

us-gaap:OperatingLeaseLiabilityNoncurrent

us-gaap:OperatingLeaseLiabilityNoncurrent


Operating
Period End2021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-04-01
Value8.1598.6859.1899.669101010119.329.559.8
Percentage of OperatingLeaseLiabilityNoncurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets1.21.21.31.27.58.310.48.85.13.80.0

Lessee Operating Lease Liability Payments Due Year Five

us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive

us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive


Lessee
Period End2021-03-31
Value2482000.0
Percentage of LesseeOperatingLeaseLiabilityPaymentsDueYearFive100.0
Percentage of Assets0.3

Lessee Operating Lease Liability Payments Due After Year Five

us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive

us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive


Lessee
Period End2021-03-31
Value416000.0
Percentage of LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive100.0
Percentage of Assets0.1

Operating Lease Liability

us-gaap:OperatingLeaseLiability

us-gaap:OperatingLeaseLiability


Operating
Period End2021-03-312020-09-30
Value1011
Percentage of OperatingLeaseLiability100.0100.0
Percentage of Assets1.58.7

Lessee Operating Lease Liability Payments Due

us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue

us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue


Lessee
Period End2021-03-312020-09-302019-12-312019-09-30
Value14151815
Percentage of LesseeOperatingLeaseLiabilityPaymentsDue100.0100.0100.0100.0
Percentage of Assets2.011.814.08.2

Lessee Operating Lease Liability Undiscounted Excess Amount

us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount

us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount


Lessee
Period End2021-03-312020-09-30
Value3519000.04207000.0
Percentage of LesseeOperatingLeaseLiabilityUndiscountedExcessAmount100.0100.0
Percentage of Assets0.53.1

Stockholders Equity

us-gaap:StockholdersEquity

us-gaap:StockholdersEquity


Stockholders
Period End2021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-03-312016-02-02
Value-382.927-399.626-353.965-270.657-199.779-134.61-108.277-48.88817794.3344674603782118145166186-37.925-0.2230.0
Percentage of StockholdersEquity100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.00.0
Percentage of Assets-56.4-54.9-48.8-35.0-147.1-106.3-102.2-37.79.431.72.523.244.139.031.759.687.289.390.095.9-1901.00.00.0

us-gaap:StockholdersEquity us-gaap:StatementEquityComponents

us-gaap:AccumulatedOtherComprehensiveIncome


Stockholders
Period End2021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-03-312016-02-02
Value-17.285-17.285-17.285-17.285-11.54-5.121-1.646-0.823-0.031-0.3120.5070.2270.3770.4490.024-0.0910.2880.4040.140.00.0
Percentage of StockholdersEquity4.54.34.96.45.83.81.51.7-0.2-0.411.70.50.50.70.1-0.10.20.30.1-0.00.0
Percentage of Assets-2.5-2.4-2.4-2.2-8.5-4.0-1.6-0.6-0.0-0.10.30.10.20.30.0-0.10.20.20.10.00.0
Percentage of Assets us-gaap:AccumulatedOtherComprehensiveIncome0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:AdditionalPaidInCapital


Stockholders
Period End2021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-03-312016-02-02
Value763725709711702694684678657649505473430350266262256254251249171.4340.0
Percentage of StockholdersEquity-199.5-181.5-200.4-262.8-351.7-515.8-632.1-1386.93812.3816.711671.71013.2580.4582.4705.5319.4216.4174.1150.9134.1-45.9-643.00.0
Percentage of Assets112.499.797.991.9517.6548.1646.1523.6357.5259.0292.4234.8255.8227.0223.5190.3188.7155.5135.9128.6872.90.00.0
Percentage of Assets us-gaap:AdditionalPaidInCapital0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:CommonStock


Stockholders
Period End2021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-03-312016-02-02
Value0.0020.0020.0020.0020.0020.0020.0020.0020.0020.0020.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.001
Percentage of StockholdersEquity-0.0-0.0-0.0-0.0-0.0-0.0-0.0-0.00.00.00.00.00.00.00.00.00.00.00.00.0-0.0-0.40.0
Percentage of Assets0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.10.00.0
Percentage of Assets us-gaap:CommonStock0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:RetainedEarnings


Stockholders
Period End2021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-03-312016-02-02
Value-1129.399-1107.808-1046.148-964.785-890.936-823.874-791.014-726.101-640.497-569.929-502.025-427.011-356.378-290.608-228.474-180.221-138.444-108.536-85.097-63.423-55.34-1.6570.0
Percentage of StockholdersEquity294.9277.2295.6356.5446.0612.0730.51485.2-3712.2-716.3-11583.4-913.7-480.9-483.1-605.6-219.3-116.6-74.3-51.0-34.1145.9743.00.0
Percentage of Assets-166.2-152.2-144.3-124.6-656.2-650.3-746.8-560.7-348.1-227.2-290.2-211.7-211.9-188.3-191.8-130.6-101.7-66.4-45.9-32.7-2773.90.00.0
Percentage of Assets us-gaap:RetainedEarnings0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

Common Stock Value

us-gaap:CommonStockValue

us-gaap:CommonStockValue


Common
Period End2021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-03-31
Value2000.02000.02000.02000.02000.02000.02000.02000.02000.02000.01000.01000.01000.01000.01000.01000.01000.01000.01000.01000.01000.01000.0
Percentage of CommonStockValue100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.10.0

Additional Paid In Capital

us-gaap:AdditionalPaidInCapital

us-gaap:AdditionalPaidInCapital


Additional
Period End2021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-03-31
Value763725709711702694684678657649505473430350266262256254251249171.434
Percentage of AdditionalPaidInCapital100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets112.499.797.991.9517.6548.1646.1523.6357.5259.0292.4234.8255.8227.0223.5190.3188.7155.5135.9128.6872.90.0

Retained Earnings Accumulated Deficit

us-gaap:RetainedEarningsAccumulatedDeficit

us-gaap:RetainedEarningsAccumulatedDeficit


Retained
Period End2021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-03-31
Value-1129400000.0-1107800000.0-1046100000.0-964780000.0-890940000.0-823870000.0-791010000.0-726100000.0-640500000.0-569930000.0-502020000.0-427010000.0-356380000.0-290610000.0-228470000.0-180220000.0-138440000.0-108540000.0-85097000.0-63423000.0-55340000.0-1657000.0
Percentage of RetainedEarningsAccumulatedDeficit100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets-166.2-152.2-144.3-124.6-656.2-650.3-746.8-560.7-348.1-227.2-290.2-211.7-211.9-188.3-191.8-130.6-101.7-66.4-45.9-32.7-2773.90.0

Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value

us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue

us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue


Adjustments
Period End2021-09-302021-06-302020-12-312020-09-302020-06-302019-12-312019-09-302019-06-302018-12-312018-09-302018-06-30
Value11117.016.9247.812197.8796.414.6694.5294.053
Percentage of AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets0.00.00.00.00.00.00.00.00.00.00.0

us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue us-gaap:StatementEquityComponents

us-gaap:AdditionalPaidInCapital


Adjustments
Period End2021-09-302021-06-302020-12-312020-09-302020-06-302019-12-312019-09-302019-06-302018-12-312018-09-302018-06-30
Value11117.016.9247.812197.8796.414.6694.5294.053
Percentage of AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets0.00.00.00.00.00.00.00.00.00.00.0
Percentage of Assets us-gaap:AdditionalPaidInCapital0.00.00.00.00.00.00.00.00.00.00.0

Net Cash Provided By Used In Operating Activities

us-gaap:NetCashProvidedByUsedInOperatingActivities

us-gaap:NetCashProvidedByUsedInOperatingActivities


Net
Period End2021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-31
Value36-113.177-92.943574-48.592-61.984-19.229-66.795-68.337-66.811-53.108-62.099-64.126-44.755-34.989-30.905-24.804-26.557-10.665-6.863-0.6870.00.0
Percentage of NetCashProvidedByUsedInOperatingActivities100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.00.00.0
Percentage of RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer145.4-383.50.041635.00.0-186.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

Net Cash Provided By Used In Investing Activities

us-gaap:NetCashProvidedByUsedInInvestingActivities

us-gaap:NetCashProvidedByUsedInInvestingActivities


Net
Period End2021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-31
Value-13.383-74.39121-15.54-2.699-12.1241211-27.553-0.139-0.518-0.328-0.193-0.197-0.229-0.218-0.067-0.09-0.598-0.3690.00.00.0
Percentage of NetCashProvidedByUsedInInvestingActivities100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.00.00.00.0
Percentage of RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer-53.2-252.10.0-1126.90.0-36.40.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

Net Cash Provided By Used In Financing Activities

us-gaap:NetCashProvidedByUsedInFinancingActivities

us-gaap:NetCashProvidedByUsedInFinancingActivities


Net
Period End2021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-31
Value114.135326161820.2758.263-0.2221372791757914300.0120.0-0.2211990.760.00.0
Percentage of NetCashProvidedByUsedInFinancingActivities100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.00.0100.0100.0100.00.00.0
Percentage of RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer43.714.00.04474.70.0246.60.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect

us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect

us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect


Cash
Period End2021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
Value34-183.433-39.03620108.082-6.429-47.3-96.11270-26.404291035-20.249
Percentage of CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer135.9-621.60.044982.80.024.20.00.00.00.00.00.00.00.00.0

Amortization Of Financing Costs

us-gaap:AmortizationOfFinancingCosts us-gaap:CounterpartyName

us-gaap:AmortizationOfFinancingCosts

myov:Pfizer


Amortization
Period End2021-09-302021-06-302021-03-31
Value600000.0600000.0500000.0
Percentage of AmortizationOfFinancingCosts100.0100.0100.0

Increase Decrease In Accounts Receivable

us-gaap:IncreaseDecreaseInAccountsReceivable

us-gaap:IncreaseDecreaseInAccountsReceivable


Increase
Period End2021-09-302021-06-30
Value3.7947.038
Percentage of IncreaseDecreaseInAccountsReceivable100.0100.0

Increase Decrease In Inventories

us-gaap:IncreaseDecreaseInInventories

us-gaap:IncreaseDecreaseInInventories


Increase
Period End2021-09-302021-06-30
Value1969000.01561000.0
Percentage of IncreaseDecreaseInInventories100.0100.0

Net Cash Provided By Used In Operating Activities

us-gaap:NetCashProvidedByUsedInOperatingActivities

us-gaap:NetCashProvidedByUsedInOperatingActivities


Net
Period End2021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-31
Value36-113.177-92.943574-48.592-61.984-19.229-66.795-68.337-66.811-53.108-62.099-64.126-44.755-34.989-30.905-24.804-26.557-10.665-6.863-0.6870.00.0
Percentage of NetCashProvidedByUsedInOperatingActivities100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.00.00.0
Percentage of RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer145.4-383.50.041635.00.0-186.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

Net Income Loss

us-gaap:NetIncomeLoss

us-gaap:NetIncomeLoss


Net
Period End2021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-31
Value-21591000.0-61660000.0-81363000.0-73849000.0-67062000.0-32860000.0-64913000.0-85604000.0-70568000.0-67904000.0-75014000.0-70633000.0-65770000.0-62134000.0-48253000.0-41777000.0-29908000.0-23317000.0-21675000.0-8083000.0-34712000.0-18970000.0-1657000.0
Percentage of NetIncomeLoss100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer-85.8-209.00.0-5355.30.0-98.60.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:NetIncomeLoss us-gaap:StatementEquityComponents

us-gaap:RetainedEarnings


Net
Period End2021-09-302021-06-302020-12-312020-09-302020-06-302019-12-312019-09-302019-06-302018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-03-31
Value-21591000.0-61660000.0-73849000.0-67062000.0-32860000.0-85604000.0-70568000.0-67904000.0-70633000.0-65770000.0-62134000.0-48253000.0-41777000.0-29908000.0-23317000.0-21674000.0-8083000.0-1657000.0
Percentage of NetIncomeLoss100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer-85.8-209.0-5355.30.0-98.60.00.00.00.00.00.00.00.00.00.00.00.00.0
Percentage of RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer us-gaap:RetainedEarnings0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

Share Based Compensation

us-gaap:ShareBasedCompensation

us-gaap:ShareBasedCompensation


Share
Period End2021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-31
Value1111317.016.9247.8126.073197.9316.4524.9334.7944.7254.2443.343.2932.7492.2011.9362.012.152.6211.434
Percentage of ShareBasedCompensation100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

Net Cash Provided By Used In Investing Activities

us-gaap:NetCashProvidedByUsedInInvestingActivities

us-gaap:NetCashProvidedByUsedInInvestingActivities


Net
Period End2021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-31
Value-13.383-74.39121-15.54-2.699-12.1241211-27.553-0.139-0.518-0.328-0.193-0.197-0.229-0.218-0.067-0.09-0.598-0.3690.00.00.0
Percentage of NetCashProvidedByUsedInInvestingActivities100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.00.00.00.0
Percentage of RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer-53.2-252.10.0-1126.90.0-36.40.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

Payments To Acquire Property Plant And Equipment

us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

us-gaap:PaymentsToAcquirePropertyPlantAndEquipment


Payments
Period End2021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-31
Value737000.0302000.0583000.0151000.0275000.0292000.0393000.0139000.0518000.0328000.0193000.0197000.0229000.0218000.067000.090000.0598000.0369000.0000
Percentage of PaymentsToAcquirePropertyPlantAndEquipment100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.00.00.00.0

Net Cash Provided By Used In Financing Activities

us-gaap:NetCashProvidedByUsedInFinancingActivities

us-gaap:NetCashProvidedByUsedInFinancingActivities


Net
Period End2021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-31
Value114.135326161820.2758.263-0.2221372791757914300.0120.0-0.2211990.760.00.0
Percentage of NetCashProvidedByUsedInFinancingActivities100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.00.0100.0100.0100.00.00.0
Percentage of RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer43.714.00.04474.70.0246.60.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

Effective Income Tax Rate Continuing Operations

us-gaap:EffectiveIncomeTaxRateContinuingOperations

us-gaap:EffectiveIncomeTaxRateContinuingOperations


Effective
Period End2021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-31
Value0.69-1.5-0.481.540.2-0.02090.0005-0.0022-0.0028-0.0046-0.00050-0.0013-0.00230.00490.00510.0088-0.04880.0015-0.0036-0.0002-0.00020
Percentage of EffectiveIncomeTaxRateContinuingOperations100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.00.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.00.0

Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice


Share
Period End2021-03-312020-03-312019-03-312018-03-312017-03-312016-03-31
Value9.99.2514.469.845.060
Percentage of ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice100.0100.0100.0100.0100.00.0

Unrecognized Tax Benefits

us-gaap:UnrecognizedTaxBenefits

us-gaap:UnrecognizedTaxBenefits


Unrecognized
Period End2021-03-312020-03-312019-03-312016-12-312016-09-302016-03-31
Value4404000.03177000.00000
Percentage of UnrecognizedTaxBenefits100.0100.00.00.00.00.0

Deferred Tax Assets Valuation Allowance

us-gaap:DeferredTaxAssetsValuationAllowance

us-gaap:DeferredTaxAssetsValuationAllowance


Deferred
Period End2021-03-312020-03-312019-03-312018-03-312017-03-312016-03-31
Value20715792217.4010.0
Percentage of DeferredTaxAssetsValuationAllowance100.0100.0100.0100.0100.00.0

myov:AdjustmentsToAdditionalPaidInCapitalChangeInFairOfShareBasedCompensationExpenseRecordedToLiabilities

myov:AdjustmentsToAdditionalPaidInCapitalChangeInFairOfShareBasedCompensationExpenseRecordedToLiabilities


Adjustments
Period End2021-09-302021-06-30
Value0.9151.377
Percentage of AdjustmentsToAdditionalPaidInCapitalChangeInFairOfShareBasedCompensationExpenseRecordedToLiabilities100.0100.0

myov:AdjustmentsToAdditionalPaidInCapitalChangeInFairOfShareBasedCompensationExpenseRecordedToLiabilities us-gaap:StatementEquityComponents

us-gaap:AdditionalPaidInCapital


Adjustments
Period End2021-09-302021-06-30
Value0.9151.377
Percentage of AdjustmentsToAdditionalPaidInCapitalChangeInFairOfShareBasedCompensationExpenseRecordedToLiabilities100.0100.0

myov:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationLiabilitiesReclassifiedToEquity

myov:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationLiabilitiesReclassifiedToEquity


Adjustments
Period End2021-09-302021-06-30
Value161.862
Percentage of AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationLiabilitiesReclassifiedToEquity100.0100.0

myov:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationLiabilitiesReclassifiedToEquity us-gaap:StatementEquityComponents

us-gaap:AdditionalPaidInCapital


Adjustments
Period End2021-09-302021-06-30
Value161.862
Percentage of AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationLiabilitiesReclassifiedToEquity100.0100.0

myov:CollaborationAgreementAssetAdditions

myov:CollaborationAgreementAssetAdditions


Collaboration
Period End2021-06-30
Value100
Percentage of CollaborationAgreementAssetAdditions100.0

myov:CollaborationExpense

myov:CollaborationExpense


Collaboration
Period End2021-09-30
Value8.565
Percentage of CollaborationExpense100.0

myov:CollaborativeArrangementImputedInterest

myov:CollaborativeArrangementImputedInterest


Collaborative
Period End2021-09-302021-06-30
Value609000.0601000.0
Percentage of CollaborativeArrangementImputedInterest100.0100.0

myov:CollaborativeArrangementLiabilityCostsRecognizedAsFinancingCosts us-gaap:CounterpartyName

myov:CollaborativeArrangementLiabilityCostsRecognizedAsFinancingCosts

myov:Pfizer


Collaborative
Period End2020-12-26
Value3600000.0
Percentage of CollaborativeArrangementLiabilityCostsRecognizedAsFinancingCosts100.0

myov:ContractWithCustomerLiabilityAdditions

myov:ContractWithCustomerLiabilityAdditions


Contract
Period End2020-09-302020-06-302020-04-30
Value010000000.010000000.0
Percentage of ContractWithCustomerLiabilityAdditions0.0100.0100.0

myov:CostOfGoodsAndServicesSoldAndOperatingExpenses

myov:CostOfGoodsAndServicesSoldAndOperatingExpenses


Cost
Period End2021-09-302021-06-302020-09-302020-06-30
Value96987167
Percentage of CostOfGoodsAndServicesSoldAndOperatingExpenses100.0100.0100.0100.0

myov:DeferredRevenueAdditions1 us-gaap:CounterpartyName

myov:DeferredRevenueAdditions1

myov:Pfizer


Deferred
Period End2021-05-26
Value100
Percentage of DeferredRevenueAdditions1100.0

myov:DeferredRevenueAdditions1 us-gaap:CounterpartyName, us-gaap:StatementScenario

myov:Richter, srt:ScenarioForecast


Deferred
Period End2021-09-30
Value15
Percentage of DeferredRevenueAdditions10.0

myov:DeferredRevenueAdditions1 us-gaap:ProductOrService

myov:CollaborationAgreement


Deferred
Period End2021-09-302021-06-30
Value0.0100
Percentage of DeferredRevenueAdditions10.00.0

myov:DeferredRevenueDeductions us-gaap:ProductOrService

myov:DeferredRevenueDeductions

myov:CollaborationAgreement


Deferred
Period End2021-09-302021-06-30
Value4129
Percentage of DeferredRevenueDeductions100.0100.0

myov:DepreciationandAmortizationExcludingAmortizationofDebtIssuanceCostsandDiscounts

myov:DepreciationandAmortizationExcludingAmortizationofDebtIssuanceCostsandDiscounts


Depreciationand
Period End2021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-30
Value812000.0724000.0692000.0641000.0595000.0551000.0529000.0510000.0370000.0356000.0140000.0107000.0100000.091000.0
Percentage of DepreciationandAmortizationExcludingAmortizationofDebtIssuanceCostsandDiscounts100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

myov:FairValueRecurringBasisLiabilityGainLossIncludedInEarnings us-gaap:FairValueByLiabilityClass

myov:FairValueRecurringBasisLiabilityGainLossIncludedInEarnings

myov:DeferredCompensationShareBasedArrangementsLiabilityCurrentAndNoncurrent


Fair
Period End2021-09-302021-06-30
Value0.9151.377
Percentage of FairValueRecurringBasisLiabilityGainLossIncludedInEarnings100.0100.0

myov:FairValueRecurringBasisLiabilitySettlements us-gaap:FairValueByLiabilityClass

myov:FairValueRecurringBasisLiabilitySettlements

myov:DeferredCompensationShareBasedArrangementsLiabilityCurrentAndNoncurrent


Fair
Period End2021-09-302021-06-30
Value161.862
Percentage of FairValueRecurringBasisLiabilitySettlements100.0100.0

myov:IncreaseDecreaseInAccruedLiabilitiesCollaborationAgreementCurrent

myov:IncreaseDecreaseInAccruedLiabilitiesCollaborationAgreementCurrent


Increase
Period End2021-09-302021-06-30
Value8.9329.071
Percentage of IncreaseDecreaseInAccruedLiabilitiesCollaborationAgreementCurrent100.0100.0

myov:IncreaseDecreaseInCollaborativeArrangementLiability

myov:IncreaseDecreaseInCollaborativeArrangementLiability


Increase
Period End2021-09-302021-06-302021-03-31
Value-20.019-18.285-17.573
Percentage of IncreaseDecreaseInCollaborativeArrangementLiability100.0100.0100.0

myov:IncreaseDecreaseInCollaborativeArrangementLiability us-gaap:CounterpartyName

myov:Pfizer


Increase
Period End2021-09-302021-06-302021-03-31
Value54-17.7-16.9
Percentage of IncreaseDecreaseInCollaborativeArrangementLiability-273.796.896.2

myov:IncreaseDecreaseInDueFromCollaborators

myov:IncreaseDecreaseInDueFromCollaborators


Increase
Period End2021-06-30
Value100
Percentage of IncreaseDecreaseInDueFromCollaborators100.0

myov:IncreaseDecreaseInInterestPayableRelatedPartyNetCurrent

myov:IncreaseDecreaseInInterestPayableRelatedPartyNetCurrent


Increase
Period End2020-09-302020-06-30
Value-24000.09000.0
Percentage of IncreaseDecreaseInInterestPayableRelatedPartyNetCurrent100.0100.0

myov:IncreaseDecreaseinInterestPayableRelatedPartiesCurrent

myov:IncreaseDecreaseinInterestPayableRelatedPartiesCurrent


Increase
Period End2020-12-312020-09-302020-06-302020-03-312019-06-302019-03-31
Value0-24000.09000.0-1000.000
Percentage of IncreaseDecreaseinInterestPayableRelatedPartiesCurrent0.0100.0100.0100.00.00.0

myov:IncreaseDecreaseinOperatingLeaseLiability

myov:IncreaseDecreaseinOperatingLeaseLiability


Increase
Period End2021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-30
Value-404000.0-384000.0-372000.0-356000.0-335000.0-179000.0-190000.0-178000.0
Percentage of IncreaseDecreaseinOperatingLeaseLiability100.0100.0100.0100.0100.0100.0100.0100.0

myov:LicenseAgreementRegulatoryMilestonesPaymentsReceived us-gaap:CounterpartyName

myov:LicenseAgreementRegulatoryMilestonesPaymentsReceived

myov:Richter


License
Period End2021-07-162020-03-30
Value1525
Percentage of LicenseAgreementRegulatoryMilestonesPaymentsReceived100.0100.0

myov:NoncashIncreaseDecreaseInDeferredCompensationShareBasedArrangementsLiability

myov:NoncashIncreaseDecreaseInDeferredCompensationShareBasedArrangementsLiability


Noncash
Period End2021-09-302021-06-30
Value915000.01377000.0
Percentage of NoncashIncreaseDecreaseInDeferredCompensationShareBasedArrangementsLiability100.0100.0

myov:NoncashReclassificationOfShareBasedCompensationExpenseFromLiabilitiesToAdditionalPaidInCapital

myov:NoncashReclassificationOfShareBasedCompensationExpenseFromLiabilitiesToAdditionalPaidInCapital


Noncash
Period End2021-09-302021-06-30
Value161.862
Percentage of NoncashReclassificationOfShareBasedCompensationExpenseFromLiabilitiesToAdditionalPaidInCapital100.0100.0

myov:PaymentsForCollaborativeArrangement

myov:PaymentsForCollaborativeArrangement


Payments
Period End2021-09-302021-06-30
Value2018
Percentage of PaymentsForCollaborativeArrangement100.0100.0

myov:PaymentsForCollaborativeArrangement us-gaap:CounterpartyName

myov:Pfizer


Payments
Period End2021-09-302021-06-302021-03-31
Value201817
Percentage of PaymentsForCollaborativeArrangement99.9100.10.0

myov:PaymentsForCollaborativeArrangement us-gaap:CounterpartyName, us-gaap:IncomeStatementLocation

myov:Pfizer, myov:CollaborationExpenses


Payments
Period End2021-06-30
Value0.5
Percentage of PaymentsForCollaborativeArrangement2.7

myov:Pfizer, us-gaap:ResearchAndDevelopmentExpense


Payments
Period End2021-09-302021-06-30
Value6.37.6
Percentage of PaymentsForCollaborativeArrangement31.541.6

myov:Pfizer, us-gaap:SellingGeneralAndAdministrativeExpenses


Payments
Period End2021-09-302021-06-30
Value1410
Percentage of PaymentsForCollaborativeArrangement70.955.8

myov:ProceedsFromCollaboratorsAndLicenseFeesReceived us-gaap:CounterpartyName, us-gaap:SubsequentEventType

myov:ProceedsFromCollaboratorsAndLicenseFeesReceived

myov:Pfizer, us-gaap:SubsequentEvent


Proceeds
Period End2021-07-31
Value100
Percentage of ProceedsFromCollaboratorsAndLicenseFeesReceived100.0

myov:ProceedsFromMaturitiesPrepaymentsAndCallsOfMarketableSecurities

myov:ProceedsFromMaturitiesPrepaymentsAndCallsOfMarketableSecurities


Proceeds
Period End2021-09-302021-06-302020-09-302020-06-30
Value3.04.035113.0
Percentage of ProceedsFromMaturitiesPrepaymentsAndCallsOfMarketableSecurities100.0100.0100.0100.0

myov:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRightsQuarterlyPercentage us-gaap:TitleOfIndividual, us-gaap:AwardType, us-gaap:SubsequentEventType

myov:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRightsQuarterlyPercentage

srt:ChiefExecutiveOfficer, us-gaap:EmployeeStockOption, us-gaap:SubsequentEvent


Share
Period End2021-01-15
Value6.25
Percentage of ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRightsQuarterlyPercentage100.0

srt:ChiefExecutiveOfficer, us-gaap:RestrictedStockUnitsRSU, us-gaap:SubsequentEvent


Share
Period End2021-01-15
Value6.25
Percentage of ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRightsQuarterlyPercentage100.0

myov:ShareBasedCompensationArrangementByShareBasedPaymentAwardQuarterlyAwardVestingRightsPercentage us-gaap:TitleOfIndividual, us-gaap:AwardType

myov:ShareBasedCompensationArrangementByShareBasedPaymentAwardQuarterlyAwardVestingRightsPercentage

srt:Director, us-gaap:EmployeeStockOption


Share
Period End2021-06-30
Value0.125
Percentage of ShareBasedCompensationArrangementByShareBasedPaymentAwardQuarterlyAwardVestingRightsPercentage100.0

myov:ShareBasedPaymentArrangementSettlementAndRemeasurementOfAwardsCost

myov:ShareBasedPaymentArrangementSettlementAndRemeasurementOfAwardsCost


Share
Period End2021-09-302021-06-30
Value900000.01400000.0
Percentage of ShareBasedPaymentArrangementSettlementAndRemeasurementOfAwardsCost100.0100.0

myov:StockOptionsExercisedReceivable

myov:StockOptionsExercisedReceivable


Stock
Period End2021-09-302021-06-30
Value45000.0117000.0
Percentage of StockOptionsExercisedReceivable100.0100.0

us-gaap:AmortizationOfFinancingCostsAndDiscounts

us-gaap:AmortizationOfFinancingCostsAndDiscounts


Amortization
Period End2021-06-302021-03-312020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-03-31
Value601000.0595000.000391000.0540000.0555000.0706000.0442000.0429000.0507000.0272000.0390000.00000
Percentage of AmortizationOfFinancingCostsAndDiscounts100.0100.00.00.0100.0100.0100.0100.0100.0100.0100.0100.0100.00.00.00.00.0

us-gaap:ContractWithCustomerLiabilityRevenueRecognized

us-gaap:ContractWithCustomerLiabilityRevenueRecognized


Contract
Period End2020-09-302020-06-30
Value-3.725290298461914e-1533
Percentage of ContractWithCustomerLiabilityRevenueRecognized100.0100.0

us-gaap:ContractWithCustomerLiabilityRevenueRecognized us-gaap:CounterpartyName

myov:PfizerAndRichter


Contract
Period End2021-06-30
Value115
Percentage of ContractWithCustomerLiabilityRevenueRecognized0.0

myov:Richter


Contract
Period End2021-03-312020-06-30
Value0.033
Percentage of ContractWithCustomerLiabilityRevenueRecognized0.0100.0

us-gaap:ContractWithCustomerLiabilityRevenueRecognized us-gaap:CounterpartyName, us-gaap:SubsequentEventType

myov:Pfizer, us-gaap:SubsequentEvent


Contract
Period End2021-07-31
Value100
Percentage of ContractWithCustomerLiabilityRevenueRecognized0.0

myov:Richter, us-gaap:SubsequentEvent


Contract
Period End2021-07-31
Value15
Percentage of ContractWithCustomerLiabilityRevenueRecognized0.0

us-gaap:CostsAndExpensesRelatedParty us-gaap:CounterpartyName, us-gaap:IncomeStatementLocation, us-gaap:RelatedPartyTransaction, us-gaap:RelatedPartyTransactionsByRelatedParty

us-gaap:CostsAndExpensesRelatedParty

myov:MSG, us-gaap:SellingGeneralAndAdministrativeExpenses, myov:SunovionPharmaceuticalsIncMarketAccessServicesAgreement, us-gaap:MajorityShareholder


Costs
Period End2021-09-302020-09-30
Value1200000.01100000.0
Percentage of CostsAndExpensesRelatedParty100.0100.0

myov:SumitomoDainipponPharmaCo.Ltd., us-gaap:SellingGeneralAndAdministrativeExpenses, myov:SumitovantOtherExpensesAgreement, us-gaap:MajorityShareholder


Costs
Period End2020-09-302020-06-30
Value200000.0100000.0
Percentage of CostsAndExpensesRelatedParty18.20.0

us-gaap:CostsAndExpensesRelatedParty us-gaap:CounterpartyName, us-gaap:Range, us-gaap:IncomeStatementLocation, us-gaap:RelatedPartyTransaction, us-gaap:RelatedPartyTransactionsByRelatedParty

myov:SumitomoDainipponPharmaCo.Ltd., srt:Maximum, us-gaap:ResearchAndDevelopmentExpense, myov:SumitovantOtherExpensesAgreement, us-gaap:MajorityShareholder


Costs
Period End2021-06-30
Value100000.0
Percentage of CostsAndExpensesRelatedParty0.0

myov:SumitomoDainipponPharmaCo.Ltd., srt:Maximum, us-gaap:SellingGeneralAndAdministrativeExpenses, myov:SumitovantOtherExpensesAgreement, us-gaap:MajorityShareholder


Costs
Period End2021-06-30
Value100000.0
Percentage of CostsAndExpensesRelatedParty0.0

us-gaap:CostsAndExpensesRelatedParty us-gaap:CounterpartyName, us-gaap:RelatedPartyTransaction

myov:SumitomoDainipponPharmaCo.Ltd., myov:MarketAccessServicesAgreement


Costs
Period End2020-09-30
Value1100000.0
Percentage of CostsAndExpensesRelatedParty100.0

us-gaap:CostsAndExpensesRelatedParty us-gaap:CounterpartyName, us-gaap:RelatedPartyTransaction, us-gaap:RelatedPartyTransactionsByRelatedParty

myov:SumitomoDainipponPharmaCo.Ltd., myov:SumitovantConsultingAgreement, us-gaap:MajorityShareholder


Costs
Period End2021-03-312020-12-312020-09-302020-06-30
Value300000.0200000.0200000.0114000.0
Percentage of CostsAndExpensesRelatedParty0.00.018.20.0

myov:SumitomoDainipponPharmaCo.Ltd., myov:SunovionPharmaceuticalsIncMarketAccessServicesAgreement, us-gaap:MajorityShareholder


Costs
Period End2021-06-302021-03-312020-12-31
Value1300000.01300000.01400000.0
Percentage of CostsAndExpensesRelatedParty0.00.00.0

us-gaap:ForeignCurrencyTransactionGainBeforeTax

us-gaap:ForeignCurrencyTransactionGainBeforeTax


Foreign
Period End2020-12-312020-09-302020-06-302019-12-312019-09-302019-06-30
Value5.8916.7183.5690.567-0.1210.705
Percentage of ForeignCurrencyTransactionGainBeforeTax100.0100.0100.0100.0100.0100.0

us-gaap:ForeignCurrencyTransactionGainLossBeforeTax

us-gaap:ForeignCurrencyTransactionGainLossBeforeTax


Foreign
Period End2020-09-302020-06-30
Value6.7183.569
Percentage of ForeignCurrencyTransactionGainLossBeforeTax100.0100.0

us-gaap:IncreaseDecreaseInAccountsPayableTrade

us-gaap:IncreaseDecreaseInAccountsPayableTrade


Increase
Period End2021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-31
Value-843000.0-8676000.05434000.05349000.01620000.0-9946000.08717000.0798000.0-4185000.0-1015000.05548000.0
Percentage of IncreaseDecreaseInAccountsPayableTrade100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:IncreaseDecreaseInAccruedLiabilities

us-gaap:IncreaseDecreaseInAccruedLiabilities


Increase
Period End2020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302016-03-31
Value4.23611-0.14-16.1540.904-1.736-7.5685.279.9030.1368.040.223
Percentage of IncreaseDecreaseInAccruedLiabilities100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities

us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities


Increase
Period End2021-09-302021-06-302020-09-302020-06-30
Value3.396-1.67411-0.254
Percentage of IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities100.0100.0100.0100.0

us-gaap:IncreaseDecreaseInContractWithCustomerLiability

us-gaap:IncreaseDecreaseInContractWithCustomerLiability


Increase
Period End2020-09-302020-06-30
Value0.0-23.333
Percentage of IncreaseDecreaseInContractWithCustomerLiability0.0100.0

us-gaap:IncreaseDecreaseInDeferredRevenue

us-gaap:IncreaseDecreaseInDeferredRevenue


Increase
Period End2021-09-302021-06-302021-03-312020-12-312020-09-302020-06-30
Value-41.83970-20.9755020.0-23.333
Percentage of IncreaseDecreaseInDeferredRevenue100.0100.0100.0100.00.0100.0

us-gaap:IncreaseDecreaseInDueToRelatedPartiesCurrent

us-gaap:IncreaseDecreaseInDueToRelatedPartiesCurrent


Increase
Period End2021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-31
Value295000.0-504000.0-100000.0-656000.01170000.0114000.00-271000.075000.075000.055000.0-512000.0-4629000.03247000.0-1723000.02952000.0-1269000.0-1030000.0708000.0-713000.02861000.01153000.00
Percentage of IncreaseDecreaseInDueToRelatedPartiesCurrent100.0100.0100.0100.0100.0100.00.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.00.0

us-gaap:IncreaseDecreaseInOperatingLeaseLiability

us-gaap:IncreaseDecreaseInOperatingLeaseLiability


Increase
Period End2021-09-302021-06-302020-09-302020-06-30
Value-444000.0-425000.0-372000.0-356000.0
Percentage of IncreaseDecreaseInOperatingLeaseLiability100.0100.0100.0100.0

us-gaap:IncreaseDecreaseInOtherCurrentAssets

us-gaap:IncreaseDecreaseInOtherCurrentAssets


Increase
Period End2020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-31
Value661000.0648000.00-262000.0-527000.01036000.0-237000.0-222000.050000.0384000.0-288000.0967000.00-976000.03074000.0-100000.00100000.000
Percentage of IncreaseDecreaseInOtherCurrentAssets100.0100.00.0100.0100.0100.0100.0100.0100.0100.0100.0100.00.0100.0100.0100.00.0100.00.00.0

us-gaap:IncreaseDecreaseInOtherOperatingAssets

us-gaap:IncreaseDecreaseInOtherOperatingAssets


Increase
Period End2021-09-302021-06-30
Value-1686000.0-112000.0
Percentage of IncreaseDecreaseInOtherOperatingAssets100.0100.0

us-gaap:IncreaseDecreaseInOtherOperatingLiabilities

us-gaap:IncreaseDecreaseInOtherOperatingLiabilities


Increase
Period End2021-09-302021-06-302021-03-312020-12-312020-09-302020-06-30
Value3000.0-1699000.0-1715000.0-306000.0531000.0855000.0
Percentage of IncreaseDecreaseInOtherOperatingLiabilities100.0100.0100.0100.0100.0100.0

us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets

us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets


Increase
Period End2021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-31
Value498000.03916000.05356000.02568000.0-3758000.01101000.0-3817000.02117000.01276000.0-1501000.0-2180000.03995000.02677000.0563000.0-140000.01541000.0-1444000.01961000.02068000.01115000.038000.000
Percentage of IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.00.00.0

us-gaap:InterestExpenseRelatedParty

us-gaap:InterestExpenseRelatedParty


Interest
Period End2020-09-302020-06-302020-03-312019-12-312019-06-302019-03-312018-12-31
Value2115000.02184000.01425000.016000.0000
Percentage of InterestExpenseRelatedParty100.0100.0100.0100.00.00.00.0

us-gaap:InterestExpenseRelatedParty us-gaap:CounterpartyName, us-gaap:DebtInstrument, us-gaap:LongtermDebtType, us-gaap:RelatedPartyTransactionsByRelatedParty

myov:SumitomoDainipponPharmaCo.Ltd., myov:LetterAgreementwithSumitomoDainipponPharmaCo.Ltd., us-gaap:SecuredDebt, us-gaap:MajorityShareholder


Interest
Period End2021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-06-30
Value2900000.02900000.02900000.02600000.02100000.02200000.01300000.0100000.00
Percentage of InterestExpenseRelatedParty0.00.00.00.099.3100.791.2625.00.0

us-gaap:InvestmentIncomeInterest

us-gaap:InvestmentIncomeInterest


Investment
Period End2021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-30
Value100000.078000.033000.032000.038000.0108000.0247000.0597000.0942000.0766000.0881000.0000
Percentage of InvestmentIncomeInterest100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.00.00.00.0

us-gaap:LeaseCost

us-gaap:LeaseCost


Lease
Period End2020-09-302020-06-302020-03-312019-12-312019-09-302019-06-30
Value829000.0819000.0833000.0795000.0565000.0528000.0
Percentage of LeaseCost100.0100.0100.0100.0100.0100.0

us-gaap:OperatingLeaseCost

us-gaap:OperatingLeaseCost


Operating
Period End2020-09-302020-06-302020-03-312019-12-312019-09-302019-06-30
Value729000.0729000.0729000.0729000.0519000.0519000.0
Percentage of OperatingLeaseCost100.0100.0100.0100.0100.0100.0

us-gaap:OperatingLeasePayments

us-gaap:OperatingLeasePayments


Operating
Period End2020-09-302020-06-302019-09-302019-06-30
Value734000.0729000.0501000.0496000.0
Percentage of OperatingLeasePayments100.0100.0100.0100.0

us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent

us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent


Other
Period End2021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-31
Value0-5745000.0-6419000.0-3475000.0-823000.0-792000.0281000.0-819000.0280000.0-150000.0-72000.0425000.0115000.0-379000.0-116000.0264000.0140000.00000
Percentage of OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent0.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.00.00.00.00.0

us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent

us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent


Other
Period End2021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-31
Value0-5745000.0-6419000.0-3475000.0-823000.0-792000.0281000.0-819000.0280000.0-150000.0-72000.0425000.0115000.0-379000.0-116000.0264000.0140000.00000
Percentage of OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent0.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.00.00.00.00.0

us-gaap:OtherNoncashIncomeExpense

us-gaap:OtherNoncashIncomeExpense


Other
Period End2021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-31
Value1000.0-145000.0-299000.0-94000.0806000.0805000.0-344000.0713000.0-639000.0-384000.0213000.0-425000.0116000.00
Percentage of OtherNoncashIncomeExpense100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.00.0

us-gaap:PaymentsToAcquireMarketableSecurities

us-gaap:PaymentsToAcquireMarketableSecurities


Payments
Period End2021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-31
Value1678161813140.04.916270.00.00.0
Percentage of PaymentsToAcquireMarketableSecurities100.0100.0100.0100.0100.0100.00.0100.0100.00.00.00.0

us-gaap:ProceedsFromCollaborators us-gaap:CounterpartyName

us-gaap:ProceedsFromCollaborators

myov:Pfizer


Proceeds
Period End2020-12-26
Value150
Percentage of ProceedsFromCollaborators100.0

us-gaap:ProceedsFromRelatedPartyDebt

us-gaap:ProceedsFromRelatedPartyDebt


Proceeds
Period End2021-03-312020-12-312020-09-302020-06-302020-03-312019-06-302019-03-31
Value456060800.00.00.0
Percentage of ProceedsFromRelatedPartyDebt100.0100.0100.0100.00.00.00.0

us-gaap:ProceedsFromRelatedPartyDebt us-gaap:CounterpartyName, us-gaap:DebtInstrument, us-gaap:LongtermDebtType, us-gaap:RelatedPartyTransaction, us-gaap:SubsequentEventType

myov:SumitomoDainipponPharmaCo.Ltd., myov:LetterAgreementwithSumitomoDainipponPharmaCo.Ltd., us-gaap:SecuredDebt, us-gaap:MajorityShareholder, us-gaap:SubsequentEvent


Proceeds
Period End2021-01-312020-10-312020-07-31
Value456060
Percentage of ProceedsFromRelatedPartyDebt0.00.00.0

us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities

us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities


Proceeds
Period End2020-12-312020-09-302020-06-302020-03-312019-06-302019-03-31
Value3.45113.0120.00.0
Percentage of ProceedsFromSaleAndMaturityOfMarketableSecurities100.0100.0100.0100.00.00.0

us-gaap:ProceedsFromStockOptionsExercised

us-gaap:ProceedsFromStockOptionsExercised


Proceeds
Period End2021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-03-31
Value114.1351.4251.7061.3882.190.2750.3530.00.3140.5290.3050.390.0760.020.0040.0120.00.00.00.0
Percentage of ProceedsFromStockOptionsExercised100.0100.0100.0100.0100.0100.0100.0100.00.0100.0100.0100.0100.0100.0100.0100.0100.00.00.00.00.0

us-gaap:RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer

us-gaap:RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer


Revenue
Period End2021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302019-06-30
Value2529201.3790.0330.0
Percentage of RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer100.0100.0100.0100.00.0100.00.0

us-gaap:RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer us-gaap:CounterpartyName

myov:Pfizer


Revenue
Period End2021-09-302021-06-302021-03-31
Value252921
Percentage of RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer100.1100.0100.1

us-gaap:RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer us-gaap:ProductOrService

myov:AmortizationOfRegulatoryMilestone


Revenue
Period End2021-09-302021-06-30
Value4.1988.535
Percentage of RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer16.728.9

us-gaap:SeveranceCosts1 us-gaap:StatementScenario, us-gaap:TitleOfIndividual

us-gaap:SeveranceCosts1

srt:ScenarioForecast, myov:FormerChiefExecutiveOfficer


Severance
Period End2021-03-31
Value1900000.0
Percentage of SeveranceCosts1100.0

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost


Share
Period End2021-09-302020-03-312019-12-31
Value1.3-8.41.8
Percentage of ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost100.0100.0100.0

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost us-gaap:StatementScenario, us-gaap:TitleOfIndividual

srt:ScenarioForecast, myov:FormerChiefExecutiveOfficer


Share
Period End2021-03-31
Value12
Percentage of ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost0.0

us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage us-gaap:TitleOfIndividual

us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage

srt:ChiefFinancialOfficer


Sharebased
Period End2021-08-31
Value25.0
Percentage of SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage100.0

us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage us-gaap:TitleOfIndividual, us-gaap:AwardType

srt:Director, us-gaap:EmployeeStockOption


Sharebased
Period End2021-06-30
Value0.3333
Percentage of SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage0.0

us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage us-gaap:TitleOfIndividual, us-gaap:AwardType, us-gaap:SubsequentEventType

srt:ChiefExecutiveOfficer, us-gaap:EmployeeStockOption, us-gaap:SubsequentEvent


Sharebased
Period End2021-01-15
Value25.0
Percentage of SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage0.0

srt:ChiefExecutiveOfficer, us-gaap:RestrictedStockUnitsRSU, us-gaap:SubsequentEvent


Sharebased
Period End2021-01-15
Value25.0
Percentage of SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage0.0

us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation

us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation


Stock
Period End2020-12-312020-09-302020-06-302019-12-312019-09-302019-06-302018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-31
Value1.7061.3882.190.3540.06.414.6694.5294.0533.0683.0462.5191.9541.5521.439
Percentage of StockIssuedDuringPeriodValueShareBasedCompensation100.0100.0100.0100.00.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation us-gaap:StatementEquityComponents

us-gaap:AdditionalPaidInCapital


Stock
Period End2020-12-312020-09-302020-06-302019-12-312019-09-302019-06-302018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-31
Value1.7061.3882.190.3540.06.414.6694.5294.0533.0683.0462.5191.9541.5521.439
Percentage of StockIssuedDuringPeriodValueShareBasedCompensation100.0100.0100.0100.00.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised

us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised


Stock
Period End2021-09-302021-06-302020-09-302020-06-302018-06-302018-03-312017-12-312017-09-30
Value114.2521.3882.190.0760.020.0040.012
Percentage of StockIssuedDuringPeriodValueStockOptionsExercised100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised us-gaap:StatementEquityComponents

us-gaap:AdditionalPaidInCapital


Stock
Period End2021-09-302021-06-302020-09-302020-06-302018-06-302018-03-312017-12-312017-09-30
Value114.2521.3882.190.0760.020.0040.012
Percentage of StockIssuedDuringPeriodValueStockOptionsExercised100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:VariableLeaseCost

us-gaap:VariableLeaseCost


Variable
Period End2020-09-302020-06-302020-03-312019-12-312019-09-302019-06-30
Value100000.090000.0104000.066000.046000.09000.0
Percentage of VariableLeaseCost100.0100.0100.0100.0100.0100.0

dei:EntityPublicFloat

dei:EntityPublicFloat


Entity
Period End2020-09-30
Value559
Percentage of EntityPublicFloat100.0

myov:AccruedAndOtherLiabilitiesCurrent

myov:AccruedAndOtherLiabilitiesCurrent


Accrued
Period End2021-09-302021-06-302021-03-312020-03-31
Value46424429
Percentage of AccruedAndOtherLiabilitiesCurrent100.0100.0100.0100.0

myov:AccruedCommercialExpensesCurrent

myov:AccruedCommercialExpensesCurrent


Accrued
Period End2021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-31
Value7226000.08065000.07770000.07889000.05898000.03190000.0818000.0
Percentage of AccruedCommercialExpensesCurrent100.0100.0100.0100.0100.0100.0100.0

myov:AccruedLiabilitiesCollaborationAgreementCurrent

myov:AccruedLiabilitiesCollaborationAgreementCurrent


Accrued
Period End2021-09-302021-06-302021-03-31
Value19111.954
Percentage of AccruedLiabilitiesCollaborationAgreementCurrent100.0100.0100.0

myov:AccruedLiabilitiesCollaborationAgreementCurrent us-gaap:CounterpartyName

myov:Pfizer


Accrued
Period End2021-09-302021-06-302021-03-31
Value20111.9
Percentage of AccruedLiabilitiesCollaborationAgreementCurrent100.299.897.2

myov:AccruedLiabilitiesCollaborationAgreementReimbursementOfExpensesCurrent us-gaap:CounterpartyName

myov:AccruedLiabilitiesCollaborationAgreementReimbursementOfExpensesCurrent

myov:Pfizer


Accrued
Period End2021-09-302021-06-302021-03-31
Value115.20.1
Percentage of AccruedLiabilitiesCollaborationAgreementReimbursementOfExpensesCurrent100.0100.0100.0

myov:AccruedLiabilitiesCollaborationAgreementReimbursementOfExpensesCurrent us-gaap:CounterpartyName, us-gaap:IncomeStatementLocation

myov:Pfizer, us-gaap:ResearchAndDevelopmentExpense


Accrued
Period End2021-06-30
Value0.4
Percentage of AccruedLiabilitiesCollaborationAgreementReimbursementOfExpensesCurrent7.7

myov:Pfizer, us-gaap:SellingGeneralAndAdministrativeExpenses


Accrued
Period End2021-06-30
Value4.8
Percentage of AccruedLiabilitiesCollaborationAgreementReimbursementOfExpensesCurrent92.3

myov:AccruedLiabilitiesCollaborationAgreementShareOfProfitsCurrent us-gaap:CounterpartyName

myov:AccruedLiabilitiesCollaborationAgreementShareOfProfitsCurrent

myov:Pfizer


Accrued
Period End2021-09-302021-06-302021-03-31
Value8600000.05800000.01800000.0
Percentage of AccruedLiabilitiesCollaborationAgreementShareOfProfitsCurrent100.0100.0100.0

myov:AccruedResearchandDevelopmentCurrent

myov:AccruedResearchandDevelopmentCurrent


Accrued
Period End2021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-03-31
Value7.3547.8948.544191715153036414642343525189.737
Percentage of AccruedResearchandDevelopmentCurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

myov:AccruedSalesDiscountsRebatesAndAllowancesCurrent

myov:AccruedSalesDiscountsRebatesAndAllowancesCurrent


Accrued
Period End2021-09-302021-06-302021-03-31
Value104.7371.315
Percentage of AccruedSalesDiscountsRebatesAndAllowancesCurrent100.0100.0100.0

myov:CollaborationAgreementAsset

myov:CollaborationAgreementAsset


Collaboration
Period End2021-06-30
Value100
Percentage of CollaborationAgreementAsset100.0

myov:CollaborativeArrangementLiability

myov:CollaborativeArrangementLiability


Collaborative
Period End2021-09-302021-06-302021-03-31
Value84104121
Percentage of CollaborativeArrangementLiability100.0100.0100.0

myov:CollaborativeArrangementLiability us-gaap:CounterpartyName

myov:Pfizer


Collaborative
Period End2020-12-312020-12-26
Value138146
Percentage of CollaborativeArrangementLiability0.00.0

myov:CollaborativeArrangementLiability us-gaap:CounterpartyName, us-gaap:FairValueByMeasurementFrequency

myov:Pfizer, us-gaap:FairValueMeasurementsNonrecurring


Collaborative
Period End2021-03-31
Value146
Percentage of CollaborativeArrangementLiability120.1

myov:CollaborativeArrangementLiabilityCurrent

myov:CollaborativeArrangementLiabilityCurrent


Collaborative
Period End2021-09-302021-06-302021-03-312020-12-31
Value841049292
Percentage of CollaborativeArrangementLiabilityCurrent100.0100.0100.0100.0

myov:CollaborativeArrangementLiabilityNoncurrent

myov:CollaborativeArrangementLiabilityNoncurrent


Collaborative
Period End2021-03-312020-12-31
Value2946
Percentage of CollaborativeArrangementLiabilityNoncurrent100.0100.0

myov:DeferredCompensationShareBasedArrangementsLiabilitiesCurrentAndNoncurrentMeasurementInput us-gaap:AwardType, us-gaap:MeasurementInputType

myov:DeferredCompensationShareBasedArrangementsLiabilitiesCurrentAndNoncurrentMeasurementInput

us-gaap:EmployeeStockOption, us-gaap:MeasurementInputExpectedTerm


Deferred
Period End2021-09-302021-06-302021-03-31
Value300.0500.00.78
Percentage of DeferredCompensationShareBasedArrangementsLiabilitiesCurrentAndNoncurrentMeasurementInput100.0100.0100.0

us-gaap:EmployeeStockOption, us-gaap:MeasurementInputPriceVolatility


Deferred
Period End2021-09-302021-06-302021-03-31
Value487.0537.0729.0
Percentage of DeferredCompensationShareBasedArrangementsLiabilitiesCurrentAndNoncurrentMeasurementInput162.3107.493461.5

us-gaap:EmployeeStockOption, us-gaap:MeasurementInputRiskFreeInterestRate


Deferred
Period End2021-09-302021-06-302021-03-31
Value0.40.60.6
Percentage of DeferredCompensationShareBasedArrangementsLiabilitiesCurrentAndNoncurrentMeasurementInput0.10.176.9

myov:DeferredNetProductRevenueCurrent

myov:DeferredNetProductRevenueCurrent


Deferred
Period End2021-03-31
Value162000.0
Percentage of DeferredNetProductRevenueCurrent100.0

myov:DeferredTaxAssetsLeasingArrangements

myov:DeferredTaxAssetsLeasingArrangements


Deferred
Period End2021-03-312020-03-312019-03-31
Value2317000.02633000.00
Percentage of DeferredTaxAssetsLeasingArrangements100.0100.00.0

myov:DueFromCollaborators

myov:DueFromCollaborators


Due
Period End2021-06-30
Value100
Percentage of DueFromCollaborators100.0

myov:FairValueRecurringBasisLiabilityValue us-gaap:FairValueByLiabilityClass

myov:FairValueRecurringBasisLiabilityValue

myov:DeferredCompensationShareBasedArrangementsLiabilityCurrentAndNoncurrent


Fair
Period End2021-09-302021-06-302021-03-31
Value5.7692121
Percentage of FairValueRecurringBasisLiabilityValue100.0100.0100.0

myov:LesseeOperatingLeaseLiabilityToBePaidDueAfterYearFour

myov:LesseeOperatingLeaseLiabilityToBePaidDueAfterYearFour


Lessee
Period End2020-09-30
Value2898000.0
Percentage of LesseeOperatingLeaseLiabilityToBePaidDueAfterYearFour100.0

myov:LesseeOperatingLeaseRestrictionorCovenantReducedLetterofCreditifConditionsareMet us-gaap:RealEstateAndAccumulatedDepreciationDescriptionOfProperty, us-gaap:PropertyPlantAndEquipmentByType

myov:LesseeOperatingLeaseRestrictionorCovenantReducedLetterofCreditifConditionsareMet

myov:BrisbaneCaliforniaOfficeSpace, us-gaap:Building


Lessee
Period End2021-03-31
Value200000.0
Percentage of LesseeOperatingLeaseRestrictionorCovenantReducedLetterofCreditifConditionsareMet100.0

myov:LesseeOperatingSubleaseAreaofLeased us-gaap:RealEstateAndAccumulatedDepreciationDescriptionOfProperty, us-gaap:PropertyPlantAndEquipmentByType

myov:LesseeOperatingSubleaseAreaofLeased

myov:AdditionalBrisbaneCaliforniaOfficeSpace, us-gaap:Building


Lessee
Period End2021-03-31
Value20116.0
Percentage of LesseeOperatingSubleaseAreaofLeased100.0

myov:RelatedPartyOwnershipInterestHeldByRelatedParty us-gaap:CounterpartyName, us-gaap:RelatedPartyTransactionsByRelatedParty

myov:RelatedPartyOwnershipInterestHeldByRelatedParty

myov:SumitomoDainipponPharmaCo.Ltd., us-gaap:MajorityShareholder


Related
Period End2021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-27
Value53.852.953.553.553.70.540.5210.502
Percentage of RelatedPartyOwnershipInterestHeldByRelatedParty100.0100.0100.0100.0100.0100.0100.0100.0

myov:SocialSecurityTaxEmployerDeferralCARESAct

myov:SocialSecurityTaxEmployerDeferralCARESAct


Social
Period End2021-09-302021-06-302021-03-312020-12-312020-09-30
Value1800000.01800000.01800000.01800000.01200000.0
Percentage of SocialSecurityTaxEmployerDeferralCARESAct100.0100.0100.0100.0100.0

us-gaap:AccruedProfessionalFeesCurrent

us-gaap:AccruedProfessionalFeesCurrent


Accrued
Period End2021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-03-31
Value625000.01075000.0935000.01334000.01068000.0763000.01126000.01446000.01053000.0971000.0370000.0417000.0624000.0551000.0439000.0133000.01174000.0410000.0481000.0164000.0
Percentage of AccruedProfessionalFeesCurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:AccruedRoyaltiesCurrentAndNoncurrent us-gaap:OtherCommitments

us-gaap:AccruedRoyaltiesCurrentAndNoncurrent

myov:TakedaLicenseAgreement


Accrued
Period End2021-09-302021-06-302021-03-31
Value1600000.0900000.0300000.0
Percentage of AccruedRoyaltiesCurrentAndNoncurrent100.0100.0100.0

us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax

us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax


Accumulated
Period End2021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-03-31
Value-17285000.0-17285000.0-17285000.0-17285000.0-11540000.0-5121000.0-1646000.0-823000.0-31000.0-312000.0507000.0227000.0377000.0449000.024000.0-91000.0288000.0404000.0140000.00
Percentage of AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.00.0

us-gaap:AreaOfRealEstateProperty us-gaap:RealEstateAndAccumulatedDepreciationDescriptionOfProperty, us-gaap:PropertyPlantAndEquipmentByType

us-gaap:AreaOfRealEstateProperty

myov:BrisbaneCaliforniaOfficeSpace, us-gaap:Building


Area
Period End2021-03-31
Value40232.0
Percentage of AreaOfRealEstateProperty100.0

us-gaap:AssetsFairValueDisclosure

us-gaap:AssetsFairValueDisclosure


Assets
Period End2020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-31
Value706969188414312112665
Percentage of AssetsFairValueDisclosure100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:AssetsFairValueDisclosure us-gaap:FairValueByAssetClass

us-gaap:CommercialPaper


Assets
Period End2020-12-312020-09-302020-06-302020-03-31
Value6556487.042
Percentage of AssetsFairValueDisclosure93.680.369.138.3

us-gaap:CorporateBondSecurities


Assets
Period End2020-09-30
Value3.0
Percentage of AssetsFairValueDisclosure4.3

us-gaap:MoneyMarketFunds


Assets
Period End2020-12-312020-09-302020-06-302020-03-31
Value0.0030.2914.98811
Percentage of AssetsFairValueDisclosure0.00.47.161.7

us-gaap:MunicipalBonds


Assets
Period End2020-12-312020-09-302020-06-30
Value4.4990.51216
Percentage of AssetsFairValueDisclosure6.40.723.7

us-gaap:USTreasuryBillSecurities


Assets
Period End2020-09-30
Value10.0
Percentage of AssetsFairValueDisclosure14.3

us-gaap:AssetsFairValueDisclosure us-gaap:FairValueByAssetClass, us-gaap:FairValueByFairValueHierarchyLevel

us-gaap:CommercialPaper, us-gaap:FairValueInputsLevel2


Assets
Period End2020-12-312020-09-302020-06-302020-03-31
Value6556487.042
Percentage of AssetsFairValueDisclosure93.680.369.138.3

us-gaap:CorporateBondSecurities, us-gaap:FairValueInputsLevel2


Assets
Period End2020-09-30
Value3.0
Percentage of AssetsFairValueDisclosure4.3

us-gaap:MoneyMarketFunds, us-gaap:FairValueInputsLevel1


Assets
Period End2020-12-312020-09-302020-06-302020-03-31
Value0.0030.2914.98811
Percentage of AssetsFairValueDisclosure0.00.47.161.7

us-gaap:MunicipalBonds, us-gaap:FairValueInputsLevel2


Assets
Period End2020-12-312020-09-302020-06-30
Value4.4990.51216
Percentage of AssetsFairValueDisclosure6.40.723.7

us-gaap:USTreasuryBillSecurities, us-gaap:FairValueInputsLevel1


Assets
Period End2020-09-30
Value10.0
Percentage of AssetsFairValueDisclosure14.3

us-gaap:AssetsFairValueDisclosure us-gaap:FairValueByAssetClass, us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementFrequency

us-gaap:AgencySecurities, us-gaap:FairValueInputsLevel2, us-gaap:FairValueMeasurementsRecurring


Assets
Period End2021-03-31
Value10.0
Percentage of AssetsFairValueDisclosure0.0

us-gaap:CommercialPaper, us-gaap:FairValueInputsLevel2, us-gaap:FairValueMeasurementsRecurring


Assets
Period End2021-09-302021-06-302021-03-312020-03-31
Value214211217.042
Percentage of AssetsFairValueDisclosure0.00.00.038.3

us-gaap:MoneyMarketFunds, us-gaap:FairValueInputsLevel1, us-gaap:FairValueMeasurementsRecurring


Assets
Period End2021-09-302021-06-302021-03-312020-03-31
Value0.9134.8713611
Percentage of AssetsFairValueDisclosure0.00.00.061.7

us-gaap:MunicipalBonds, us-gaap:FairValueInputsLevel2, us-gaap:FairValueMeasurementsRecurring


Assets
Period End2021-03-31
Value1.417
Percentage of AssetsFairValueDisclosure0.0

us-gaap:AssetsFairValueDisclosure us-gaap:FairValueByAssetClass, us-gaap:FairValueByMeasurementFrequency

us-gaap:AgencySecurities, us-gaap:FairValueMeasurementsRecurring


Assets
Period End2021-03-31
Value10.0
Percentage of AssetsFairValueDisclosure0.0

us-gaap:CommercialPaper, us-gaap:FairValueMeasurementsRecurring


Assets
Period End2021-09-302021-06-302021-03-312020-03-31
Value214211217.042
Percentage of AssetsFairValueDisclosure0.00.00.038.3

us-gaap:MoneyMarketFunds, us-gaap:FairValueMeasurementsRecurring


Assets
Period End2021-09-302021-06-302021-03-312020-03-31
Value0.9134.8713611
Percentage of AssetsFairValueDisclosure0.00.00.061.7

us-gaap:MunicipalBonds, us-gaap:FairValueMeasurementsRecurring


Assets
Period End2021-03-31
Value1.417
Percentage of AssetsFairValueDisclosure0.0

us-gaap:AssetsFairValueDisclosure us-gaap:FairValueByFairValueHierarchyLevel

us-gaap:FairValueInputsLevel1


Assets
Period End2020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-31
Value0.003104.988110.0930.0530.0410.08365
Percentage of AssetsFairValueDisclosure0.014.77.161.70.10.00.00.1100.0

us-gaap:FairValueInputsLevel2


Assets
Period End2020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-31
Value7059647.042841431211260.0
Percentage of AssetsFairValueDisclosure100.085.392.938.399.9100.0100.099.90.0

us-gaap:AssetsFairValueDisclosure us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementFrequency

us-gaap:FairValueInputsLevel1, us-gaap:FairValueMeasurementsRecurring


Assets
Period End2021-09-302021-06-302021-03-312020-03-312017-03-312016-12-312016-09-302016-03-31
Value0.9134.87136110.00.00.00.0
Percentage of AssetsFairValueDisclosure0.00.00.061.70.00.00.00.0

us-gaap:FairValueInputsLevel2, us-gaap:FairValueMeasurementsRecurring


Assets
Period End2021-09-302021-06-302021-03-312020-03-312017-03-312016-12-312016-09-302016-03-31
Value218215337.0420.00.00.00.0
Percentage of AssetsFairValueDisclosure0.00.00.038.30.00.00.00.0

us-gaap:AssetsFairValueDisclosure us-gaap:FairValueByMeasurementFrequency

us-gaap:FairValueMeasurementsRecurring


Assets
Period End2021-09-302021-06-302021-03-312020-03-312017-03-312016-12-312016-09-302016-03-31
Value21921970180.00.00.00.0
Percentage of AssetsFairValueDisclosure0.00.00.0100.00.00.00.00.0

us-gaap:CashAndCashEquivalentsFairValueDisclosure us-gaap:FairValueByAssetClass

us-gaap:CashAndCashEquivalentsFairValueDisclosure

us-gaap:CommercialPaper


Cash
Period End2020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-31
Value3739417.04279130121126
Percentage of CashAndCashEquivalentsFairValueDisclosure100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:CashAndCashEquivalentsFairValueDisclosure us-gaap:FairValueByAssetClass, us-gaap:FairValueByMeasurementFrequency

us-gaap:CommercialPaper, us-gaap:FairValueMeasurementsRecurring


Cash
Period End2021-09-302021-06-302021-03-312020-03-31
Value121130124.0
Percentage of CashAndCashEquivalentsFairValueDisclosure0.00.00.056.8

us-gaap:CashCashEquivalentsAndShortTermInvestments

us-gaap:CashCashEquivalentsAndShortTermInvestments


Cash
Period End2021-09-302021-06-302021-03-312020-12-31
Value616569684745
Percentage of CashCashEquivalentsAndShortTermInvestments100.0100.0100.0100.0

us-gaap:CommonStockCapitalSharesReservedForFutureIssuance us-gaap:PlanName

us-gaap:CommonStockCapitalSharesReservedForFutureIssuance

myov:A2016EquityIncentivePlan


Common
Period End2021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-09-302016-06-302016-03-31
Value2600000.02400000.01300000.01000000.01100000.01200000.01500000.01500000.01500000.03200000.02100000.02200000.02500000.02800000.01700000.04500000.04500000.04500000.0
Percentage of CommonStockCapitalSharesReservedForFutureIssuance100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

myov:A2020InducementEquityAwardPlan


Common
Period End2021-09-302021-06-302021-03-312020-12-31
Value100000.0100000.0100000.0700000.0
Percentage of CommonStockCapitalSharesReservedForFutureIssuance3.84.27.770.0

us-gaap:ContractWithCustomerLiability

us-gaap:ContractWithCustomerLiability


Contract
Period End2020-09-302020-06-302020-03-31
Value161640
Percentage of ContractWithCustomerLiability100.0100.0100.0

us-gaap:DeferredCompensationShareBasedArrangementsLiabilityCurrent

us-gaap:DeferredCompensationShareBasedArrangementsLiabilityCurrent


Deferred
Period End2021-09-302021-06-302021-03-31
Value5.7692121
Percentage of DeferredCompensationShareBasedArrangementsLiabilityCurrent100.0100.0100.0

us-gaap:DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent us-gaap:AwardType, us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementFrequency

us-gaap:DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent

us-gaap:CommonStock, us-gaap:FairValueInputsLevel1, us-gaap:FairValueMeasurementsRecurring


Deferred
Period End2021-06-302021-03-31
Value109.523
Percentage of DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent100.0100.0

us-gaap:EmployeeStockOption, us-gaap:FairValueInputsLevel2, us-gaap:FairValueMeasurementsRecurring


Deferred
Period End2021-09-302021-06-302021-03-31
Value5.7691012
Percentage of DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent0.0100.7127.2

us-gaap:DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent us-gaap:AwardType, us-gaap:FairValueByMeasurementFrequency

us-gaap:CommonStock, us-gaap:FairValueMeasurementsRecurring


Deferred
Period End2021-06-302021-03-31
Value109.523
Percentage of DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent100.0100.0

us-gaap:EmployeeStockOption, us-gaap:FairValueMeasurementsRecurring


Deferred
Period End2021-09-302021-06-302021-03-31
Value5.7691012
Percentage of DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent0.0100.7127.2

us-gaap:DeferredRevenue

us-gaap:DeferredRevenue


Deferred
Period End2020-09-302020-06-302020-03-31
Value161640
Percentage of DeferredRevenue100.0100.0100.0

us-gaap:DeferredRevenue us-gaap:ProductOrService

myov:CollaborationAgreement


Deferred
Period End2021-09-302021-06-302021-03-312020-03-31
Value52656849740
Percentage of DeferredRevenue0.00.00.0100.0

us-gaap:DeferredRevenueCurrent

us-gaap:DeferredRevenueCurrent


Deferred
Period End2021-09-302021-06-302021-03-312020-12-312020-03-31
Value10011710010040
Percentage of DeferredRevenueCurrent100.0100.0100.0100.0100.0

us-gaap:DeferredRevenueCurrent us-gaap:ProductOrService

myov:CollaborationAgreement


Deferred
Period End2021-09-302021-06-302021-03-31
Value100117100
Percentage of DeferredRevenueCurrent100.0100.0100.0

us-gaap:Product


Deferred
Period End2021-03-31
Value0.162
Percentage of DeferredRevenueCurrent0.2

us-gaap:ProductAndServiceOther


Deferred
Period End2021-03-312020-03-31
Value10040
Percentage of DeferredRevenueCurrent100.0100.0

us-gaap:DeferredRevenueNoncurrent

us-gaap:DeferredRevenueNoncurrent


Deferred
Period End2021-09-302021-06-302021-03-312020-12-31
Value426451397418
Percentage of DeferredRevenueNoncurrent100.0100.0100.0100.0

us-gaap:DeferredRevenueNoncurrent us-gaap:ProductOrService

myov:CollaborationAgreement


Deferred
Period End2021-09-302021-06-302021-03-31
Value426451397
Percentage of DeferredRevenueNoncurrent100.0100.0100.0

us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets

us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets


Deferred
Period End2021-03-312020-03-312019-03-312018-03-31
Value5852380.0
Percentage of DeferredTaxAssetsGoodwillAndIntangibleAssets100.0100.0100.00.0

us-gaap:DeferredTaxAssetsGross

us-gaap:DeferredTaxAssetsGross


Deferred
Period End2021-03-312020-03-312019-03-312018-03-312017-03-312016-03-31
Value21016092217.6090.0
Percentage of DeferredTaxAssetsGross100.0100.0100.0100.0100.00.0

us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign

us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsForeign


Deferred
Period End2021-03-312020-03-312019-03-312018-03-312017-03-312016-03-31
Value1198438166.0190.0
Percentage of DeferredTaxAssetsOperatingLossCarryforwardsForeign100.0100.0100.0100.0100.00.0

us-gaap:DeferredTaxAssetsOther

us-gaap:DeferredTaxAssetsOther


Deferred
Period End2021-03-312020-03-312019-03-312018-03-312017-03-312016-03-31
Value7080000.04936000.02539000.0169000.0300000.00
Percentage of DeferredTaxAssetsOther100.0100.0100.0100.0100.00.0

us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch

us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch


Deferred
Period End2021-03-312020-03-312019-03-312018-03-312017-03-312016-03-31
Value9967000.06521000.07224000.02948000.0163000.00
Percentage of DeferredTaxAssetsTaxCreditCarryforwardsResearch100.0100.0100.0100.0100.00.0

us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost

us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost


Deferred
Period End2021-03-312020-03-312019-03-312018-03-312017-03-312016-03-31
Value128.5736.1062.381.3820.0
Percentage of DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost100.0100.0100.0100.0100.00.0

us-gaap:DeferredTaxLiabilitiesLeasingArrangements

us-gaap:DeferredTaxLiabilitiesLeasingArrangements


Deferred
Period End2021-03-312020-03-312019-03-31
Value2035000.02345000.00
Percentage of DeferredTaxLiabilitiesLeasingArrangements100.0100.00.0

us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment

us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment


Deferred
Period End2021-03-312020-03-312019-03-312018-03-312017-03-312016-03-31
Value651000.0409000.0406000.0175000.0255000.00
Percentage of DeferredTaxLiabilitiesPropertyPlantAndEquipment100.0100.0100.0100.0100.00.0

us-gaap:DueToRelatedPartiesCurrent

us-gaap:DueToRelatedPartiesCurrent


Due
Period End2021-09-302021-06-302021-03-312020-12-312020-09-302020-03-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-03-31
Value334000.039000.0543000.0628000.01284000.015000.0271000.0196000.0121000.066000.0578000.05207000.01960000.03683000.0731000.02000000.03030000.02448000.04838000.00
Percentage of DueToRelatedPartiesCurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.00.0

us-gaap:DueToRelatedPartiesCurrent us-gaap:CounterpartyName, us-gaap:Range, us-gaap:RelatedPartyTransactionsByRelatedParty

myov:SumitomoDainipponPharmaCo.Ltd., srt:Maximum, us-gaap:MajorityShareholder


Due
Period End2021-06-30
Value100000.0
Percentage of DueToRelatedPartiesCurrent256.4

us-gaap:DueToRelatedPartiesCurrent us-gaap:CounterpartyName, us-gaap:RelatedPartyTransaction, us-gaap:RelatedPartyTransactionsByRelatedParty

myov:SumitomoDainipponPharmaCo.Ltd., myov:SumitovantConsultingAgreement, us-gaap:MajorityShareholder


Due
Period End2020-12-31
Value100000.0
Percentage of DueToRelatedPartiesCurrent15.9

myov:SumitomoDainipponPharmaCo.Ltd., myov:SunovionPharmaceuticalsIncMarketAccessServicesAgreement, us-gaap:MajorityShareholder


Due
Period End2021-09-302021-06-302021-03-312020-12-31
Value300000.0400000.0400000.0600000.0
Percentage of DueToRelatedPartiesCurrent89.81025.673.795.5

us-gaap:DueToRelatedPartiesCurrent us-gaap:CounterpartyName, us-gaap:RelatedPartyTransactionsByRelatedParty

myov:SumitomoDainipponPharmaCo.Ltd., us-gaap:MajorityShareholder


Due
Period End2021-03-31
Value100000.0
Percentage of DueToRelatedPartiesCurrent18.4

us-gaap:DueToRelatedPartiesCurrentAndNoncurrent us-gaap:RelatedPartyTransactionsByRelatedParty

us-gaap:DueToRelatedPartiesCurrentAndNoncurrent

us-gaap:MajorityShareholder


Due
Period End2021-03-31
Value100000.0
Percentage of DueToRelatedPartiesCurrentAndNoncurrent100.0

us-gaap:DueToRelatedPartiesNoncurrent

us-gaap:DueToRelatedPartiesNoncurrent


Due
Period End2021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-03-31
Value3583583583132531931130.0
Percentage of DueToRelatedPartiesNoncurrent100.0100.0100.0100.0100.0100.0100.00.0

us-gaap:EmployeeRelatedLiabilitiesCurrent

us-gaap:EmployeeRelatedLiabilitiesCurrent


Employee
Period End2021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-03-31
Value17172013126.9949.3098.6663.81.6325.0243.9252.4231.2292.7921.8381.0140.40.7970.0
Percentage of EmployeeRelatedLiabilitiesCurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.00.0

us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized

us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized


Employee
Period End2021-09-302021-06-302021-03-312020-12-312020-09-30
Value109102626665
Percentage of EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized100.0100.0100.0100.0100.0

us-gaap:InventoryFinishedGoodsNetOfReserves

us-gaap:InventoryFinishedGoodsNetOfReserves


Inventory
Period End2021-09-302021-06-302021-03-31
Value3250000.0968000.0448000.0
Percentage of InventoryFinishedGoodsNetOfReserves100.0100.0100.0

us-gaap:InventoryRawMaterialsNetOfReserves

us-gaap:InventoryRawMaterialsNetOfReserves


Inventory
Period End2021-09-302021-06-302021-03-31
Value931000.01321000.01390000.0
Percentage of InventoryRawMaterialsNetOfReserves100.0100.0100.0

us-gaap:InventoryWorkInProcessNetOfReserves

us-gaap:InventoryWorkInProcessNetOfReserves


Inventory
Period End2021-09-302021-06-302021-03-31
Value1960000.01883000.0773000.0
Percentage of InventoryWorkInProcessNetOfReserves100.0100.0100.0

us-gaap:InvestmentsFairValueDisclosure us-gaap:FairValueByAssetClass

us-gaap:InvestmentsFairValueDisclosure

us-gaap:CommercialPaper


Investments
Period End2020-12-312020-09-302020-06-302020-03-31
Value27166.83.0
Percentage of InvestmentsFairValueDisclosure100.0100.0100.0100.0

us-gaap:InvestmentsFairValueDisclosure us-gaap:FairValueByAssetClass, us-gaap:FairValueByMeasurementFrequency

us-gaap:CommercialPaper, us-gaap:FairValueMeasurementsRecurring


Investments
Period End2021-09-302021-06-302021-03-312020-03-31
Value93809.03.0
Percentage of InvestmentsFairValueDisclosure0.00.00.0100.0

us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear

us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear


Lessee
Period End2020-09-302019-09-30
Value1476000.01009000.0
Percentage of LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear100.0100.0

us-gaap:LettersOfCreditOutstandingAmount us-gaap:PropertyPlantAndEquipmentByType

us-gaap:LettersOfCreditOutstandingAmount

us-gaap:Vehicles


Letters
Period End2021-03-31
Value600000.0
Percentage of LettersOfCreditOutstandingAmount100.0

us-gaap:LettersOfCreditOutstandingAmount us-gaap:RealEstateAndAccumulatedDepreciationDescriptionOfProperty, us-gaap:PropertyPlantAndEquipmentByType

myov:AdditionalBrisbaneCaliforniaOfficeSpace, us-gaap:Building


Letters
Period End2021-03-31
Value200000.0
Percentage of LettersOfCreditOutstandingAmount33.3

myov:BrisbaneCaliforniaOfficeSpace, us-gaap:Building


Letters
Period End2021-03-31
Value500000.0
Percentage of LettersOfCreditOutstandingAmount83.3

us-gaap:LiabilitiesFairValueDisclosure us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementFrequency

us-gaap:LiabilitiesFairValueDisclosure

us-gaap:FairValueInputsLevel1, us-gaap:FairValueMeasurementsRecurring


Liabilities
Period End2021-06-302021-03-31
Value109.523
Percentage of LiabilitiesFairValueDisclosure100.0100.0

us-gaap:FairValueInputsLevel2, us-gaap:FairValueMeasurementsRecurring


Liabilities
Period End2021-09-302021-06-302021-03-31
Value5.7691012
Percentage of LiabilitiesFairValueDisclosure0.0100.7127.2

us-gaap:LiabilitiesFairValueDisclosure us-gaap:FairValueByMeasurementFrequency

us-gaap:FairValueMeasurementsRecurring


Liabilities
Period End2021-09-302021-06-302021-03-31
Value5.7692121
Percentage of LiabilitiesFairValueDisclosure0.0200.7227.2

us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity us-gaap:CounterpartyName, us-gaap:DebtInstrument, us-gaap:LongtermDebtType, us-gaap:RelatedPartyTransactionsByRelatedParty, us-gaap:SubsequentEventType

us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity

myov:SumitomoDainipponPharmaCo.Ltd., myov:NewLetterAgreementWithSumitomoDainipponPharmaCoLtd, us-gaap:SecuredDebt, us-gaap:MajorityShareholder, us-gaap:SubsequentEvent


Line
Period End2020-08-05
Value200
Percentage of LineOfCreditFacilityMaximumBorrowingCapacity100.0

us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity us-gaap:CounterpartyName, us-gaap:DebtInstrument, us-gaap:LongtermDebtType, us-gaap:RelatedPartyTransaction, us-gaap:SubsequentEventType

us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity

myov:SumitomoDainipponPharmaCo.Ltd., myov:LetterAgreementwithSumitomoDainipponPharmaCo.Ltd., us-gaap:SecuredDebt, us-gaap:MajorityShareholder, us-gaap:SubsequentEvent


Line
Period End2021-01-312020-10-312020-07-31
Value4186146
Percentage of LineOfCreditFacilityRemainingBorrowingCapacity100.0100.0100.0

us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity us-gaap:CounterpartyName, us-gaap:DebtInstrument, us-gaap:LongtermDebtType, us-gaap:RelatedPartyTransactionsByRelatedParty

myov:SumitomoDainipponPharmaCo.Ltd., myov:LetterAgreementwithSumitomoDainipponPharmaCo.Ltd., us-gaap:SecuredDebt, us-gaap:MajorityShareholder


Line
Period End2021-09-302021-06-302021-03-312020-12-312020-09-302020-06-30
Value41414186146206
Percentage of LineOfCreditFacilityRemainingBorrowingCapacity0.00.00.00.00.00.0

us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour us-gaap:CounterpartyName, us-gaap:DebtInstrument, us-gaap:LongtermDebtType, us-gaap:RelatedPartyTransactionsByRelatedParty

us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour

myov:SumitomoDainipponPharmaCo.Ltd., myov:LetterAgreementwithSumitomoDainipponPharmaCo.Ltd., us-gaap:SecuredDebt, us-gaap:MajorityShareholder


Long
Period End2021-03-31
Value358
Percentage of LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour100.0

us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent us-gaap:RealEstateAndAccumulatedDepreciationDescriptionOfProperty

us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent

myov:BrisbaneCaliforniaOfficeSpace


Operating
Period End2020-09-30
Value12.3
Percentage of OperatingLeaseWeightedAverageDiscountRatePercent100.0

us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent us-gaap:RealEstateAndAccumulatedDepreciationDescriptionOfProperty, us-gaap:PropertyPlantAndEquipmentByType

myov:BrisbaneCaliforniaOfficeSpace, us-gaap:Building


Operating
Period End2021-03-31
Value12.3
Percentage of OperatingLeaseWeightedAverageDiscountRatePercent0.0

us-gaap:OperatingLossCarryforwards us-gaap:StatementGeographical

us-gaap:OperatingLossCarryforwards

country:CH


Operating
Period End2021-03-312020-03-312019-03-312018-03-31
Value876615376155
Percentage of OperatingLossCarryforwards100.0100.0100.0100.0

country:GB


Operating
Period End2021-03-312020-03-312019-03-312018-03-31
Value3124146.7
Percentage of OperatingLossCarryforwards3.53.93.84.3

country:IE


Operating
Period End2021-03-312020-03-312019-03-312018-03-31
Value0.20.10.0320.023
Percentage of OperatingLossCarryforwards0.00.00.00.0

us-gaap:RestrictedCash

us-gaap:RestrictedCash


Restricted
Period End2021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-03-31
Value109.0872.9872.9871.9871.3741.3741.3741.3741.125
Percentage of RestrictedCash100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:RestrictedCash dei:LegalEntity

myov:SunovionPharmaceuticalsInc


Restricted
Period End2021-09-302021-06-302021-03-31
Value7.17.11.0
Percentage of RestrictedCash70.378.133.5

us-gaap:RevenueRemainingPerformanceObligation

us-gaap:RevenueRemainingPerformanceObligation


Revenue
Period End2020-09-302020-06-302020-03-31
Value161650
Percentage of RevenueRemainingPerformanceObligation100.0100.0100.0

us-gaap:RevenueRemainingPerformanceObligation us-gaap:CounterpartyName

myov:Richter


Revenue
Period End2021-06-302021-03-312020-12-312020-03-312020-03-30
Value1616165050
Percentage of RevenueRemainingPerformanceObligation0.00.00.0100.00.0

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue us-gaap:AwardType

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue

myov:RestrictedStockandRestrictedStockUnits


Share
Period End2021-03-312020-03-312019-03-312018-03-312017-03-312016-03-31
Value12.6810.7110.99.395.10
Percentage of ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue100.0100.0100.0100.0100.00.0

us-gaap:PerformanceShares


Share
Period End2021-03-312020-03-31
Value7.997.78
Percentage of ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue63.072.6

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice


Share
Period End2021-03-31
Value9.77
Percentage of ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice100.0

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue


Share
Period End2021-03-312020-03-312019-03-312018-03-312017-03-312016-03-31
Value904.1465040100.0
Percentage of ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue100.0100.0100.0100.0100.00.0

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue


Share
Period End2021-03-31
Value90
Percentage of ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue100.0

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice


Share
Period End2021-03-31
Value9.9
Percentage of ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice100.0

us-gaap:SharePrice us-gaap:FairValueByMeasurementFrequency

us-gaap:SharePrice

us-gaap:FairValueMeasurementsRecurring


Share
Period End2021-06-302021-03-31
Value22.7720.58
Percentage of SharePrice100.0100.0

us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1

us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1


Sharebased
Period End2021-03-31
Value58
Percentage of SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1100.0

us-gaap:TaxCreditCarryforwardAmount us-gaap:StatementGeographical, us-gaap:TaxCreditCarryforward

us-gaap:TaxCreditCarryforwardAmount

country:US, us-gaap:Research


Tax
Period End2021-03-312020-03-31
Value7700000.07600000.0
Percentage of TaxCreditCarryforwardAmount100.0100.0

stpr:CA, us-gaap:Research


Tax
Period End2021-03-312020-03-31
Value2300000.01900000.0
Percentage of TaxCreditCarryforwardAmount29.925.0

Line plots across dimensions of each concept


us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecurities
(None,)
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amountus-gaap: Antidilutive Securities Excluded From Computation Of Earnings Per Share By Antidilutive Securities
TTM Greenblatt ROC
_
(None,)
T T M  Greenblatt  R O C_
us-gaap:AllocatedShareBasedCompensationExpense
us-gaap:IncomeStatementLocation
(None,)
Allocated Share Based Compensation Expenseus-gaap: Income Statement Location
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:ProductOrService
(None,)
Revenue From Contract With Customer Excluding Assessed Taxus-gaap: Product Or Service
us-gaap:StockholdersEquity
us-gaap:StatementEquityComponents
(None,)
Stockholders Equityus-gaap: Statement Equity Components
us-gaap:StockholdersEquity
us-gaap:StatementEquityComponents
(None,)
Stockholders Equityus-gaap: Statement Equity Components